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CHAPTER 1 
GENERAL INTRODUCTION 
THE METABOLISM OF XENOBIOTIC COMPOUNDS 
During evolution organisms developed more or less specific 
biochemical systems to metabolize xenobiotic, i.e. body foreign, 
chemicals, taken up from their environment, into easily excret-
able products. The capacity to perform this so-called biotrans-
formation did especially evolve in higher vertebrates, including 
man. Although the enzyme systems, involved in this process, are 
present in many tissues, the main organ concerned in xenobiotic 
metabolism is the liver (Gram and Gillette, 1971; La Du et al., 
1971). In general, these compounds such as drugs, food additives 
and environmental contaminants may enter the body via different 
routes after which they are distributed throughout the biological 
system according to their physico-chemical properties. In order 
to facilitate elimination, lipophilic molecules are transformed 
to more hydrophilic products by introduction of polar groups. 
This is predominantly realized by oxidative reactions, catalyzed 
by liver microsomal enzymes, such as hydroxylations, oxidative 
dealkylations and deamlnations, whereas to a lesser extent re-
ductive and hydrolytic processes are involved. These molecular 
transformations are designated as phase I reactions (Williams, 
1959). A second possibility to introduce hydrophilic groups is 
offered by conjugation of xenobiotic compounds with polar mole-
cules such as glucuronate, acetate and sulphate, being endo-
genously present in an activated, transferable state. These 
conjugations, referred to as phase II reactions (Williams, 1959), 
are mediated by a number of more or less specific transferases 
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and occur either directly or following a phase I conversion. 
The sequential processes that xenobiotic compounds are subjected 
to within the organism are schematically presented in Figure 1. 
UPTAKE *• DISTRIBUTION 
METABOLISM 
phase I 
oxidation 
reduction 
hydrolysis 
:^x::::: 
phase II 
glucuronidation 
acetylation 
sulfation 
• EXCRETION 
Fig. 1 Sahematio representation of the biological fate of body 
foreign aompounds 
FORMATION OF CHEMICALLY REACTIVE METABOLITES 
In general the capacity to deal with body-foreign chemicals 
via its biotransformation apparatus has to be considered as a 
defense mechanism of the organism. Especially the last two de-
cades, however, an increasing amount of information has become 
available concerning the conversion of "safe" parent xenobiotic 
compounds to intermediary metabolites, that show deleterious 
effects on various body components (Brodie et al., 1971; Gillette 
et al., 1974). Primarily due to an oxidative conversion, often 
in combination with a coniugative step, a number of chemicals 
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may be activated to electrophilic species, which are able to attack 
nucleophilic sites of cellular constituents such as lipids, proteins 
and nucleic acids (Lutz, 1979). These interactions may cause a more 
or less severe damage, indicated as chemical lesions, resulting in 
loss of cell viability and eventually leading to necrosis and 
tissue degeneration (Mitchell et al., 1973; Reíd and Krishna, 1973). 
Convincing evidence has been presented as well that these reactive 
products may induce somatic as well as heritable mutations by in-
teraction with the genetic apparatus. A considerable number of 
studies revealed that these intermediates can also initiate the 
complex process of neoplastic transformation, leading to carcino-
genic effects (Arcos and Argus, 1974; Heidelberger, 1975; Miller, 
1970; Weisburger, 1978; Weisburger and Williams, 1980). For this 
reason in the etiology of human cancer an important role is at-
tributed to these electrophilic intermediates (Hiatt et al., 1977). 
Chemicals that are prone to metabolic activation by the organism 
belong to different chemical classes, such as polynuclear homo-
cyclic and heterocyclic aromatic hydrocarbons (Sims and Grover, 
1974) , aromatic amines (Kriek, 1974) , and N-mtroso compounds 
(Druckrey et al., 1967, Magee and Barnes, 1967; Montesano and 
Bartsch, 1976) . 
TOXIFICATIOK AND DETOXIFICATION 
As pointed out before, the metabolic activation of the 
chemicals mentioned above is predominantly accomplished by an 
oxidative reaction, that is catalyzed by a membrane bound multi-
enzyme complex, mainly localized in the endoplasmic reticulum 
of the parenchymal liver cell. This enzyme system is commonly 
referred to as microsomal mono-oxygenase (MMO). The involvement 
of certain cytochromes like P450 or P448 and the requirement of 
NADPH and molecular oxygen have been extensively studied (Esta-
brook et al·., 1972). Due to this oxidative conversion polycyclic 
aromatic hydrocarbons and other unsaturated compounds can be 
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provided with a nucleophilic epoxide group (Garner, 1976; Jerina 
and Daly, 1974; Sims and Grover, 1974), whereas aromatic amines 
may be transformed into N-hydroxy derivatives, which on their 
turn are esterified to become ultimately reactive (Bartsch et 
al., 1972; Cramer et al., 1960; Irving and Wiseman, 1971; Miller 
and Miller, 1969) . Besides a toxification pathway by which these 
particular toxic metabolites are formed, also detoxifying 
mechanisms are provided, thus rendering the electrophilic inter­
mediates inactive. This can be realized by conjugation of the 
reactive center with the endogenous nucleophile glutathione 
(GSH), usually catalyzed by glutathione-S-transferases (Chasseaud, 
1973), whereas epoxides can also be detoxified by means of epoxide 
hydratases, giving rise to dihydrodiols (Oesch, 1973). These in­
activating systems are most predominant in liver, although a 
number of extra-hepatic tissues are not completely devoid of 
them. Consequently, the ability of a particular xenobiotic com­
pound to exert a deleterious action is strongly dependent on the 
balance between activating and inactivating pathways. In evaluat­
ing the toxicological potential of a certain compound, both meta­
bolic routes should be considered. It may be clear that any 
disturbance or change in the dynamic equilibrium between the 
various enzyme reactions involved, would result in an altered 
steady-state concentration of the toxic metabolites, and may 
consequently lead to a change in toxic potency. In Fig. 2 the 
relation between toxification and detoxification with respect 
to the appearance of adverse effects is schematically presented. 
THE USE OF INTACT LIVER CELLS IN BIOCHEMICAL TOXICOLOGY 
Since the liver is primarily responsible for the metabolism 
of xenobiotic compounds and indirectly for the occurrence of 
toxic phenomena, a vast number of гп vitro biotransformation 
studies deal with liver homogenates or subcellular liver frac­
tions, usually microsomal preparations, to mimic in vivo meta-
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Fig. 2 Sahematic representation of the relationship between 
toxifying and detoxifying pathways (after Henderson, 
Ею·. J. Drug Meteo. Pharmaaokin. ¿, 1-14, 1978). 
bolle features. These homogenate fractions, however, may give a 
false representation, both qualitatively and quam titatively, of 
the overall biotransformation process in the intact cell. For 
instance, these subcellular preparations cannot account for rate 
limiting factors such as uptake of chemicals, their intracellular 
distribution and the release of their metabolites by the intact 
cell. In addition, homogenization and fractionation of liver 
tissue may modify the organization of the micro-environment in 
which biotransformational enzymes are functional. Furthermore, 
in order to express their oxidative capacity, subcellular liver 
preparations are usually equipped with very high, non physio-
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logical levels of NADPH or NADPH regenerating components. How­
ever, one of the major shortcomings of this kind of preparations 
is due to an imperfect representation of sequential reactions 
like microsomal oxidation and subsequent conjugation, which take 
place in the intact cell. It should be emphasized that particular­
ly conjugation reactions, that are catalyzed by enzymes located in 
different cellular compartments and depend on the generation of 
different cofactors, are much less operative in these subcellular 
preparations. 
In order to fill up the gap between гп V'ivo systems, which are 
much too complex to permit detailed studies on basic metabolic 
features, and subcellular i-n vitro systems the use of isolated 
liver cells in the study of xenobiotic metabolism was proposed 
some years ago (Henderson and Dewaide, 1969) . They offer a 
greater versatility than f.i. the perfused liver, since suspen­
sions of isolated hepatocytes are free of other hepatic cell 
populations. In addition, their environment can be easily con­
trolled, whereas several variables can be measured simultaneously 
using cells derived from a single liver. Moreover, isolated 
hepatocytes resemble in their structural and biochemical proper­
ties the in VÌVO situation much more closely than subcellular 
liver fractions do. 
By the introduction of the collagenase perfusion technique -
that enabled the isolation of large amounts of viable parenchymal 
liver cells from a single liver, usually from rats - (see Chapter 
2: Isolation of parenchymal liver cells) the liver cell became 
accessible as an experimental model for studies on hepatic meta-
bolism of xenobiotic compounds. 
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STUDIES ON XENOBIOTIC METABOLISM IN ISOLATED LIVER CELLS 
Suspensions of freshly isolated liver cells 
Suspensions of freshly isolated rat liver cells were found to 
have a cytochrome P450 content that closely corresponds with 
that of the parent liver (Fahl et al., 1979), being in a func-
tional, oxidized state (Moldeus et al., 1974). These cells were 
capable to keep up high enough levels of NADPH to perform oxi-
dative metabolism at an optimal rate without the need for 
additional glucose (Billings et al., 1977; Moldeus et al., 
1974). Furthermore, a number of microsomal mono-oxygenase 
activities of freshly isolated rat liver cells, such as amino-
pyrine-N-demethylase, aniline hydroxylase and aryl hydrocarbon 
hydroxylase were found to-be comparable to those of intact liver 
(Guzelian et al., 1977). Besides the presence of a functional 
in vivo like microsomal mono-oxygenase system, it was shown by 
several studies that these cells can perform conjugative meta-
bolic reactions like glucuronidation and sulfation (Andersson 
et al., 1978; Billings et al., 1977; Burke et al., 1977; Moldeus 
et al., 1979) and GSH conjugation (Burke et al., 1977; Moldeus, 
1978; Thor et al., 1978) without the need for additional co-
factors. These observations may illustrate the usefulness of 
freshly isolated liver cells as a tool to overcome the gap 
between in vivo and pure in vitro studies with respect to xeno-
biotic metabolism. However, since these cells survive for only 
approximately 5 hours in suspension under optimal conditions, 
their applicability is limited to rather short-term investiga-
tions . 
Maintenanee cultures of liver cells 
In order to make the isolated liver cell accessible to long-term 
studies on xenobiotic metabolism, that deal with phenomena like 
induction, hormonal control etc., culturing conditions were 
created that enabled the isolated hepatocytes to survive for 
several weeks in a non-proliferating state (Bissell et al., 
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1973; Bonney et al., 1974; Michalopoulos and Pitot, 1975). How-
ever, hepatocytes kept in maintenance cultures tend to dedif-
ferentiate in time, illustrated by the rapid decline of their 
cytochrome P450 content and the decrease in biotransformational 
capacity (Fahl et al., 1979; Guzelian et al., 1977). Also several 
morphological alterations have been reported. These changes may 
eventually result in a cell system that does not bear any rela-
tionship with the hepatic function in vivo anymore. In order to 
overcome this handicap, studies were undertaken to artificially 
maintain liver cell characteristics in culture, for instance by 
the addition of several hormones to the culture medium (Decad 
et al., 1977; Michaloppulos et al., 1976). Although these at-
tempts were not completely unsuccessful, a great amount of work 
is still needed to provide the optimal conditions to preserve 
the highly differentiated capacity of hepatocytes to perform 
xenobiotic metabolism. 
THE USE OF ISOLATED LIVER CELLS IN TOXICITY EVALUATION 
As mentioned before, toxic properties of chemicals often 
emerge as a consequence of a metabolic conversion, which pri-
marily takes place in the liver. Whether a metabolic activation 
actually results in a toxic response depends on the dynamic 
balance between toxifying and detoxifying mechanisms. Therefore, 
isolated liver cells alldw a reliable reflection of the relation 
between biotransformation and the occurrence of adverse effects. 
When applying isolated liver cells in toxicity studies, two dif-
ferent approaches may be followed: 
- the hepatocytes serve as the metabolizing component, whereas 
detection of the toxic response occurs with another biological 
object devoid of any substantial capacity to perform xenobiotic 
metabolism. Thereto, the reactive metabolites have to leave the 
liver cell and reach their targets elsewhere. Interesting 
studies on this issue have been reported using mutations 
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(Langenbach et al., 1978; San and Williams, 1977), neoplastic 
transformation (Poiley et al., 1979) , or growth suppression 
(Wiebkin et al., 1978) in cultures of mammalian cells as para-
meters for toxic action. 
the hepatocytes function both as a metabolizing and a response 
component. In this case reactive metabolites are formed in the 
immediate vicinity of target components, that belong to the 
same cellular system. Therefore, one may expect this approach 
to be more sensitive in the evaluation of toxic effects as a 
consequence of metabolic conversion. Studies on this issue 
are in progress now, and some data have been reported recently, 
using different endpoints for toxicity such as loss of cellular 
integrity (Moldeus, 1978;. Thor et al., 1979), lipid peroxida-
tion (Högberg et al., 1975), changes in hepatocellular enzyme 
activities (Lowing et al., 1979), DNA damage resulting in DNA 
repair (Michalopoulos et al., 1978; Williams, 1977) and muta-
genic response (Tong and Williams, 1980). 
OUTLINE OF THE THESIS 
In this thesis attention is focussed on the application of 
isolated rat hepatocytes as metabolic entity in the study of 
genotoxic effects, caused by xenobiotic compounds. In particular, 
studies were undertaken to investigate the role of metabolic con-
version in the generation of reactive intermediary products, giv-
ing rise to adverse effects on the genetic level. Thereto, two 
parameters for genotoxicity were employed: the occurrence of DNA 
repair effects within the hepatocytes and the induction of bac-
terial mutagenic features. 
After a detailed description of the procedure routinally employed 
for the high-yield preparation of isolated parenchymal rat liver 
cells (Chapter 2), some basic information is presented on the 
application of DNA repair and bacterial mutagenicity as para-
meters for genotoxic effects (Chapter 3 and 4 respectively). 
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In chapter 5 data are presented which illustrate the capacity of 
isolated rat hepatocytes to both activate and inactivate xeno-
blotlc chemicals. The main part of the thesis (Chapters 6-11) 
consists of six scientific papers in which studies on the role 
of metabolic conversion by the intact hepatocyte with respect 
to the occurrence of genotoxic phenomena ¿re presented. Thereto, 
it was studied whether certain model substrates could be acti-
vated by hepatocellular metabolism to exert genotoxic effects. 
Information on the relevance of certain metabolic features with 
respect to the occurrence of these adverse effects will be pre-
sented, whereas the impact of the use of isolated hepatocytes 
as metabolic component in genotoxicity evaluation will be dis-
cussed. 
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CHAPTER 2 
ISOLATION OF PARENCHYMAL LIVER CELLS 
INTRODUCTION 
During the past a great variety of techniques have been 
employed in order to prepare isolated hepatocytes. Former pro­
cedures that imply merely mechanical dispersion of liver tissue, 
for instance by homogenization, pipetting and shaking with glass 
beads, have proven to be inadequate to give cells in a viable 
and functional state. 
The use of chelators to loosen the intercellular connec­
tions prior to mechanical treatment offered some improvement. 
In this respect Ca -chelators such as citrate (Henderson and 
Dewaide, 1969) and EDTA have been used. Chelation of К by 
tetraphenylboron has also been claimed to enhance liver dis­
persion (Casanello and Gerschenson, 1970). However, the yield 
of intact viable cells obtainable by these methods was very 
poor. 
Since the introduction of enzymatic dispersion techniques 
much progress has been made in the field of liver cell isola­
tion. Although the proteolytic enzymes trypsine, pronase and 
lysozyme were effective in tissue dispersion, they were also 
found to be injurious to the cells (Laws and Stickland, 1961) . 
These problems were overcome by the use of a mixture of col-
lagenase and hyaluronidase as a dispersing agent, first applied 
on slices of liver tissue (Howard et al., 1967; Howard and 
Pesch, 1968). Berry and Friend (1969) adapted this method to a 
perfusion of the liver with collagenase under physiological 
25 
conditions, resulting in an almost 100% yield of isolated 
parenchymal liver cells from male rats. Cells that were iso-
lated in this way retained their ultra-structural integrity 
(Berry and Friend, 1969; Muller et al., 1972) and from a bio-
chemical point of view they were in a functional state. For 
instance, they were able to synthesize proteins, RNA and lipids 
(Jezyk and Liberty, 1969; Capuzzi et al., 1971) , they expressed 
gluconeogenic activity (Ingebretsen and Wagle, 1972; Zahlten 
and Stratman, 1974), glycogenolysis and glycogen synthesis 
could be stimulated by glucagon and insulin respectively 
(Wagle, 1975) , whereas cells isolated from regenerating rat 
liver showed semiconservative DNA replication (Hirsiger et al., 
1972). The ability of isolated liver cells to metabolize xeno-
biotic compounds is dealt with in chapter 1. 
A systematic evaluation of the collagenase perfusion 
technique was performed by Seglen (1972, 1973). In the studies 
presented in this thesis the collagenase perfusion technique, 
with slight modifications, was consequently applied. A detailed 
description is given below. 
ISOLATION PROCEDURE 
Sterility précautions 
Parenchymal liver cells were isolated under strictly sterile 
conditions. For that purpose, all surgical equipment, labora-
tory glassware and solutions were autoclaved before use. 
Solutions containing thermo-labile components were sterilized 
by filtration through a 0,20 pm bacterial filter (Millipore). 
All operations were performed in a laminar flow cabinet, while 
the operator was wearing sterile surgical gloves. 
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Surgioal procedure 
Adult male Wistar rats, weighing 200-250 gram, were used as 
donors for the liver cells. The animal was anaesthesized with 
0.2 ml of sodium pentobarbital in saline (60 mg/ml) i.p., and 
placed on a stainless steel tray. The skin covering the abdomen 
was removed and the abdominal cavity was carefully opened. 
After displacement of the intestines to the left side of the 
abdominal cavity, 0.2 ml of a heparin solution (5000 I.U./ml) 
was slowly injected into the spleen. Care was taken not to per­
forate intestinal walls, since this would result in gross con­
tamination of the final preparation with intestinal flora. 
Subsequently the vena portas was carefully isolated and slightly 
stretched by attaching an arterial clamp to the adjacent adipose 
tissue (Fig. 1). Two loose ligatures were placed around the Vena 
portere (Fig. 2), after which cannulation was performed quickly 
using a cannula type Braunula T(G-18), Luer Lock, length 40 mm, 
0 0.75 χ 1.25 mm. Before use the cannula was filled with heparin 
solution. Care was taken that after cannulation the cannula did 
not reach beyond the branching point of the vena portae.Next, 
the two ligatures were tied. After opening the chest cavity by 
cutting the sternum, the upper vena aava was incised just be­
hind the diaphragm. 
Perfusion of the tivet· 
The liver was perfused in situ with a Ca -free buffer solu­
tion (Table 1). The experimental set-up is illustrated in Fig. 
ЗА. The peçfusion fluid, being continuously oxygenated and 
warmed to 370C, was pumped through the liver at a flow rate of 
35 ml/min. in a non-circulating way, firstly passing through a 
0.2 ym bacterial filter. Before connecting the perfusion system 
any oir left in the cannula was carefully removed, since air 
bubbles would severely disturb an effective perfusion of the 
liver. The silicone tubings used were of no-toxic quality. 
During perfusion with Ca -free buffer for 5 min, the liver 
27 
Fig. 1 Isolation of vena portae 
Ν.-
Fig, 2 Placement of ligatures around vena portae 
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Fig. S Experimental set-up for liver cell isolation 
A: perfusion in situ 
B: perfusion in vitro with aollagenase (reairaulating 
system) 
1 - oicygen supply, 2a = Ca -free perfusion solution, 
2b = aollagenase solution, 3 = peristaltic pump, 
4 - thermostated waterbath (3?0C), S = spiraled glass 
tube with water jacket, в - bacterial filter (0.2 \sm), 
7 = laminar flow cabinet 
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was prepared free from stomach, spleen and intestines. Then, 
after disconnection of the perfusion system, the vena portae 
was cleared from adjacent adipose tissue, remaining ligaments 
between liver and diaphragm were cut and the liver, thus iso­
lated, was transferred to a perfusion dish (Fig. 4). 
The liver lobes were arranged according to their in situ 
position and perfusion was continued for another 5 min. At the 
end of this period the perfusate was completely clear. Then 
40 ml of buffer solution containing collagenase (Table 1) was 
introduced to the system, after which it was switched to re­
circulation (closed system. Fig. 3B). Before use the enzyme 
solution was filtered through a 5 um filter (Millipore) to pre­
vent clotting of the bacterial filter. After approximately 
4 min the liver started to swell until finally its size was 
more than doubled. After 5 min the collagenase solution was 
refreshed and perfusion was continued for 15 min. By this time 
the liver had a rather incoherent appearance, while the per­
fusion fluid was usually leaking out of the portal region. 
After disconnection of the perfusion system, the liver was 
transferred to a glass dish and the cannula removed. 
Liberation and purification of parenahymal cells 
While holding the liver at its portal region, the Glisson 
capsules were carefully removed with a forceps (Fig. 5). 
Thereupon approximately 50 ml of filter sterilized suspension 
buffer (Table 1) were added to the dish and the liver was 
shaken gently until most of the dispersed tissue was suspended 
(Fig. 6). The remainder, representing connective and vascular 
structures, was discarded. Subsequently the crude cell sus­
pension was poured onto a filter of nylon gauze (pore size 
250 \m), mounted on a glass ring. The filtrate was poured 
slowly into an Erlenmeyer flask and shaken gently in a reci­
procating shaking waterbath for 30 min at 37 C. Next the 
suspension was filtered through a 100 μιη nylon gauze filter, 
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Fig. 4 Transfer of the isolated liver to a perfusion dish 
i 
Fig. S Removal of Glisson capsules 
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TABLE 1 
Composition of solutions used for 
liver cell isolation (after Seglen) 
HEPES 
TES* 
Tricine 
NaCl 
KCl 
СаСІ2.2Н20 
МдСІ2.6Н20 
KH2PO4 
Na2S04 
Collagenase 
Albumin 
рн 
Ca -free 
buffer 
2.4 
-
8.3 
0.5 
-
7.4 
Collagenase 
buffer 
24.0 
-
3.9 
0.5 
0.7 
0.5 
7.6 
Suspension 
buffer 
7.2 
6.9 
6.5 
4.0 
0.4 
0.18 
0.13 
0.15 
0.10 
20.0 
7.6 
Conaentrationa of the different oonstituents ore given in gram 
per liter of final buffer solution. pH was adjusted with 1 N NaOH. 
HEPES : N-2-hydroxyethylpiperazine-N'-2-ethane sulfonic aoid 
TES : N-tri8(hydroxymethyl)-methyl-2-aminoethane sulfonic 
aoid 
Triaine: N-tris(hydroxymethyl)-methyl glycine 
thus removing aggregates of mostly dead cells, and the filtrate 
was centrifugea at 50 g 4 С. After the supernatant was care­
fully pipetted off, the pelleted cells were resuspended in the 
final incubation solution and filtered once more through a 
100 um filter. 
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Fig, 6 Suspending of liver tissue and removal of connective and 
vascular structures 
Cell counting and estimation of viability 
To determine the yield of intact parenchymal liver cells, the 
total yield was corrected for the number of non-viable cells. 
For that a distinction was made on the basis of plasmamembrane 
integrity, using dye exclusion as a criterion. For this purpose 
a 50 ul sample of the final cell suspension was carefully added 
to 500 μΐ of a 0.12% Trypan Blue solution in saline, filtered 
through a 5 ym filter before use. After 1 min this mixture was 
shaken gently and a sample was quickly transferred to a Bürker-
Turk counting chamber and examined microscopically under phase 
contrast. Blue stained cells, easily recognizable by the accu-
mulation of the dye in the nuclei, were regarded as non-viable. 
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Fig. 7 Мгагозаорго impression of the final cell suspension 
Usually, under optimal conditions, the collagenase perfusion 
method as described here resulted in a total yield of 300-400 χ 
10 viable parenchymal cells from one rat liver. The amount of 
non-viable cells generally ranged from 5-10% of the total yield. 
A microscopic impression of the final cell suspension is presented 
in Fig. 7. Before use, the final cell preparation was diluted to 
the desired concentration of viable hepatocytes and kept on ice 
until required. 
DISCUSSION 
The procedure for liver cell isolation described here is 
based on a dissociation of the collagen matrix, in which the 
parenchymal cells are embedded. A combination of collagenase 
(0.05%) and hyaluronidase (0.1%), that was claimed to achieve 
optimal dispersion (Howard et al., 1967) was not found to be 
superior to the action of collagenase (0.05%) alone, as was 
also reported by Seglen (1973). 
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In an attempt to evaluate the effectiveness of different 
commercially available collagenase preparations derived from 
Clostridium histolytiaum, we found that crude preparations gave 
far better results than the purified enzyme. For this reason in 
the studies, described in this thesis, cell isolation was per-
formed with a crude enzyme preparation (Sigma, type I, Sigma 
Chemical Co., St. Louis). The observation that sequential Ca 
removal and collagenase perfusion in the presence of Ca was a 
prerequisite for optimal results (Seglen, 1973), was confirmed 
by our experiments. Omission of Ca from the collagenase buffer 
resulted in a marked reduction of liver swelling and dissocia-
tion. When, prior to collagenase perfusion, the liver was pre-
perfused with a Ca -containing buffer, no dispersion could be 
observed at all. 
The time required for the entire isolation procedure, per-
formed under strictly sterile conditions by two experienced 
operators, amounted to approximately two hours. It was found 
possible to isolate parenchymal liver cells from other rodent 
species than rat by introducing simple adaptations with respect 
to cannula size and perfusion flow. In this way, hepatocytes 
were isolated from livers of mice, hamsters and guinea pigs, 
whereas also newborn rats (1-2 weeks old) were suitable donors. 
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CHAPTER 3 
DNA REPAIR. A POSSIBLE PARAMETER FOR 
GENOTOXIC ACTION OF CHEMICALS 
INTRODUCTION 
A great number of xenobiotics, belonging to various 
chemical classes, are able to attack nucleophilic sites on 
cellular macromolecules, either directly or after a metabolic 
activation process, thus altering the structural and functional 
properties of DNA, RNA, and proteins. In these macromolecules 
some positions of their elementary constituents are especially 
vulnerable to be attacked by electrophilic reactants, like the 
3 7 8 6 1 3 
N , N , С and О positions of guanine, the N and N positions 
3 3 4 
of adenine, the N position of cytosine, the N and О positions 
of thymine, the N and N positions of histidine, the С position 
of tyrosine and the S atoms of cysteine and methionine. Also the 
phosphate groups in the nucleic acid backbone may react with cer­
tain electrophilic compounds to form phosphotnesters (Miller and 
Miller, 1974). Interactions with the DNA constituents may lead to 
apunnic sites in the DNA, single and double strand breaks, mter-
strand cross-links and may interfere with the replication process. 
Eventually, cell killing, mutagenesis and carcinogenesis may be 
deleterious consequences of these alterations. In order to ward 
off the harmful effects of environmental factors like chemicals 
and radiation on their genetic complement, prokaryotes as well 
as eukaryotes evolved mechanisms that are able to eliminate the 
damage by restoring the original DNA structure. 
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DNA-EXCISION REPAIR 
The existence of a DNA-excision repair apparatus was orig-
inally discovered in E.Coli as a mechanism to remove UV-induced 
pynmidine dimers (Setlow and Carrier, 1964). Nowadays, DNA-
excision repair is regarded as the most versatile system to deal 
with radiation and chemical induced DNA damage and appears to be 
efficient in a large range of organisms, including mammals. The 
repair process is performed by a sequence of steps, resulting in 
the excision of the damaged region and replacement of the excised 
structure. Excision repair is initiated by recognition of the 
damage and it is assumed that many factors are involved in this 
complex event, depending on the nature of the DMA modifications. 
Especially the structural relationship between DNA and proteins 
is believed to be relevant in rendering the DNA accessible, not 
only for electrophilic reactants but also for the repair enzymes 
(Cleaver, 1977) . After recognition of the damage, an incision is 
made by the action of an endonuclease, cleaving the phosphodi-
ester bond m the DNA backbone, adjacent or close to the damage. 
Subsequently, terminal nucleotides are removed by exonuclease 
action, but leaving single stranded gaps inside the DNA molecule. 
Next, these gaps are filled by polymerase catalyzed replication, 
using the opposite strand as a template after which a ligase 
joins the open ends. This entire sequence of events is generally 
defined as nucleotide excision repair. A variant of this mechan-
ism is known as base excision repair (Regand and Setlow, 1974) 
and involves the removal of a damaged base by N-glycosidase 
action, prior to scission of the phosophodiester bond by an 
endonuclease. It is believed that nucleotide excision repair 
produces gaps of about 100 nucleotides (long patch repair), 
whereas base excision repair involves only a few (3 to 4) nucleo-
tides (short patch repair). The basic scheme for the sequential 
steps involved in DNA-excision repair is given in Fig. 1, ana-
logous to the repair of UV-induced thymine dimers as presented 
by Watson (1970). 
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ооаиртепае of ohemiaally induced 
DNA damage (e.g. alkylated base) 
after récognition of damaged 
region, an incision is made 
by endonuclease action 
terminal nucleotides are removed 
by exonuolease action 
gap is filled by polymerase 
catalyzed replication 
open ends are finally joined 
by ligase action 
Fig. 1 Basic scheme for the DNA excision repair mechanism 
(after Watson, 1970, modified) 
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METHODOLOGY FOR THE MEASUREMENT OF DNA-EXCISION REPAIR 
General outline 
In the study of DNA-excision repair different techniques are 
applicable, depending on the information that is desired. In 
the analysis of molecular interactions between e.g. alkylating 
agents and DNA constituents, digested DNA fragments are separated 
and analyzed chromatographically. The appearance of strand breaks 
during DNA repair may be studied by means of sedimentation in 
alkaline sucrose gradients (Andoh and Ide, 1972). For the esti­
mation of repair replication, the incornoration of a radio-
labelled DNA precursor, usually H-thymidine ( H-TdR), is 
currently determined either by autoradiography (Rasmussen and 
Painter, 1966; San and Stich, 1975) or by quantification of the 
stimulated uptake of radioactivity by scintillation analysis 
(Liebennan et al., 1971; Lieberman and Poirier, 1973). Another 
approach is based on the incorporation of bromodeoxyundine 
(BrdUrd) by measuring the increase in buoyant density (Rasmussen 
and Painter, 1964) or the UV-induced photolysis of DMA (Regan et 
al., 1971). 
DNA-excision repair in isolated hepatooytes 
In the evaluation of the DNA modifying potency of chemicals, 
measurement of hepatocellular DNA-excision repair has been 
postulated to present a useful tool (see Chapter 1: General 
Introduction, and the observations presented in Chapter 7). 
Two methods were found to be of value for the estimation of 
hepatocellular DNA repair on a routine basis. One deals with 
the autoradiographic determination of radioactivity in the 
nucleus as a result of Η-thymidine incorporation (Williams, 
1976). The other involves the measurement of radioactivity, 
incorporated into hepatocellular DNA by means of scintillation 
counting (Hsia and Kreamer, 1979; Michalopoulos et al., 1978; 
Yager and Miller, 1978). 
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DISCUSSION 
It may be assumed that for a particular compound the amount 
of DNA that has been repaired after a certain period, is propor-
tional to the damage originally induced. However, it is difficult 
to compare DNA damaging effects of different chemicals merely on 
the basis of observed repair activities, since the amount of 
excision repair depends on factors such as: the nature and fre-
quency of the induced lesions, the effectiveness of the repair 
apparatus to recognize and restore specific damage, the size of 
repaired regions (long patch vs. short patch repair) and possible 
interactions of reactive compounds with factors essentially in-
volved in the repair mechanism. 
It is even more difficult to relate mutagenic or carcinogenic 
potency to the amount of excision repair observed. Since DNA-
excision repair is considered to be an error-free process, thus 
antagonizing the DNA damage by restoring the original structure, 
it it tempting to assume an inverse relationship between DNA 
repair and genotoxic potency in quantitative terms. There are 
indications, however, that apart from the excision repair 
mechanism other repair systems are operative - although to a 
lesser extent - which are supposed to be highly error-prone and 
may therefore change a more or less reversible lesion into a 
persistent one. Since for a given chemical any profound know-
ledge about the relationship between DNA repair, mutagenesis 
and in particular carcinogenesis is virtually lacking, the use-
fulness of DNA repair as a parameter of mutagenic and carcino-
genic activity of chemicals has to be established experimentally 
yet. 
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CHAPTER 4 
BACTERIAL MUTAGENICITY AS PARAMETER 
FOR GENOTOXIC ACTION OF CHEMICALS 
INTRODUCTION 
DNA damage, caused by environmental compounds, both natural 
and man made, is supposed to be the onset of deleterious effects 
like mutagenesis and carcinogenesis (see also Chapter 3, intro-
ductory section). In fact, it is believed that cancer is the 
outcome of a somatic mutation, that gives rise to cancerous 
cells by altering cellular regulatory mechanisms. In order to 
minimize exposure to agents with mutagenic and carcinogenic 
potential, it is essential to identify these particular com-
pounds. Animal bioassays, preferentially suitable for this pur-
pose, are too expensive and laborious to be used for large scale 
testing of the enormous, still growing number of chemicals man 
is exposed to. 
For this reason, much effort has been spent recently in the 
development of rather simple tests that can be performed quickly 
with low costs in order to identify environmental chemicals with 
genotoxic properties. At this moment over 100 so-called short-
term assays have been developed (Hollstein et al., 1979), using 
prokaryotic as well as eukaryotic systems and studying genotoxic 
parameters like mutagenesis, DNA repair, chromosomal aberrations 
and neoplastic transformation (eukaryotic systems). 
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THE SALMONELLA/MAMMALIAN MICROSOME TEST 
The Salmonella/mammalian microsome test is widely used to 
detect environmental carcinogens as mutagens. This assay has 
been developed by Ames and co-workers (Ames et al., 1975) and 
utilizes specially constructed mutants of Salmonella typhirmrtum 
as tester bacteria. The standard bacterial tester strains carry 
different types of mutations within the gene coding for histidine 
biosynthesis, thus lacking the ability to grow in the absence of 
histidine. The strains TA 1535 and TA 100 contain a base pair 
substitution within the histidine Operon, whereas the strains 
TA 1537, TA 1538 and TA 98 carry a frame shift mutation. Besides 
the histidine mutation, the tester strains contain two additional 
mutations, deficiency with respect to DNA-excision repair and 
absence of a lipopolysacchande layer on the external side of 
the bacterial wall, which make them extremely sensitive to 
various types of mutagens. Upon exposure to a mutagen, a frac-
tion of the exposed bacteria will revert to histidine proto-
trophy, depending on the strain and the kind of mutagen applied. 
Since a great number of potential mutagens becomes ultimately 
mutagenic only after metabolic activation, the activating 
enzymes may be incorporated in the test system (Ames et al., 
1975, Mailing, 1971). For that purpose postmitochondrial frac-
tions of liver from rats, pretreated with inducers of the 
microsomal mono-oxygenase system like phénobarbital or Aroclor 
1254, are usually added to the system on a routine basis. In 
practice, a certain amount of bacteria cultured under condi-
tioned terms, is added to a fixed volume (usually 2 ml) of 
molten top agar (45 C ) , together with the compound being tested. 
After supplementation with the activating system (S-9 mix), this 
mixture is poured as an overlay onto a minimal agar petn dish, 
in which histidine is virtually absent. After incubation for 
48 hours at 37 C, the number of revertant colonies in both 
control (showing spontaneous revertants) and test plates is 
counted. In the estimation of the mutagenic activity of a cer-
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tain compound, it is advised that testing should be performed 
according to a standarized protocol over a wide dose range in 
order to assess a dose-response relationship. A positive result 
is usually defined as a reproducible dose-related increase in the 
number of histidine prototrophic colonies (Ames et al., 1975; 
de Serres and Shelby, 1979). Thorough evaluations of the Salmo­
nella/mammalian microsome test, commonly designated as "Ames test", 
have been performed by several laboratories (McCann et al., 1975; 
Rinkus and Legator, 1979, Sugimura et al., 1976), demonstrating 
this assay to be a powerful system in detecting carcinogens as 
mutagens. 
Prediative value 
Among the short term test systems that became popular in 
the assessment of carcinogenic activity of chemicals, the Sal­
monella/mammalian microsome assay received greatest attention 
because of its high predictivity. A correlation between carcino­
genicity and mutagenicity as high as 90% was claimed (McCann et 
al., 1975), although other authors reported somewhat lower values 
(Rinkus and Legator, 1979; Sugimura et al., 1976). However, doubts 
can be raised about the quantitative significance of the Salmo­
nella assay, especially when an external activating system is 
required for the expression of mutagenicity. By a severe simpli­
fication of the overall metabolic fate of a particular chemical, 
the final mutagenic response may be an over- as well as an under­
estimation of the actual in vivo situation. Furthermore, because 
of the tendency to develop test protocols with ever increasing 
sensitivity, it will become more difficult to differentiate be­
tween low and high genotoxic activity. Therefore, in order to 
make a more quantitative estimate of the mutagenic or carcino­
genic activity of a compound, thus enabling a more reliable risk 
assessment in case of human exposure, test systems incorporating 
a more гп vivo like metabolic capacity deserve serious considera­
tion. 
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ISOLATED HEPATOCYTES AS METABOLIZING COMPONENT IN THE SALMONELLA 
ASSAY 
As pointed out, detoxifying pathways are preserved to a much 
higher degree in isolated hepatocytes than in subcellular prepara-
tions from liver, so that these cells offer a more realistic 
reflection of in VÌVO metabolic features, than cell free systems 
do. For this reason, in the elucidation of metabolic factors in-
volved in the in VÌVO generation of mutagenic metabolites, the 
isolated hepatocyte as a metabolic component in the Salmonella 
assay may prove to be a valuable addition to conventional meta-
bolic systems. 
In this thesis, some data are presented that may illustrate the 
usefulness of isolated rat liver cells in this respect. The ex-
perimental procedure for the application of isolated liver cells 
as metabolic factor in the Salmonella assay, based either on a 
liquid preincubation or on a direct plating assay, is briefly 
outlined in Fig. 1. 
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CHAPTER 5 
SOME PRELIMINARY STUDIES ON THE 
ACTIVATING AND INACTIVATING CAPACITY 
OF ISOLATED RAT HEPATOCYTES 
INTRODUCTION 
The potency of numerous chemical compounds to exert 
adverse effects is often determined by the balance between 
toxifying and detoxifying mechanisms (see Chapter 1, fig. 2). 
As mentioned before, freshly isolated rat liver cells are able 
to perform mono-oxygenase catalyzed reactions with in VÌVO like 
capacity, whereas also the ability to carry out con]ugative 
reactions like glucuronidation, sulfation and GSH-conjugation 
is available. 
In this chapter some experimental data are presented which may 
additionally illustrate the potential value of isolated rat 
liver cells in studying biochemical reactions dealing with ac-
tivation and inactivation of xenobiotic compounds. 
GSH DEPLETION AND STYRENEGLYCOL FORMATION AFTER ADMINISTRATION 
OF STYRENE 
Styrène (vinylbenzene, phenylethene) can metabolically be 
oxidized into styrene oxide, a compound with electrophilic 
properties. Detoxification of this reactive product can proceed 
through conjugation with GSH (glutathione), catalyzed by GSH-
transferase, and by epoxide hydratase mediated styreneglycol 
(phenylethanediol) formation (Fig. 1). In order to determine 
GSH-conjugative ability, isolated liver cells were exposed to 
styrene. Depletion of hepatocellular GSH was monitored spectro-
photometrically (Brouns et al., 1979; Ellman, 1959). 
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Fig. 1 Basic scheme of the metabolic activation and inactiva-
tion of styrene 
Formation of styreneglycol, indicative of epoxide hydratase 
activity, was measured by means of a gaschromatographic method 
(Belvedere et al., 1976). 
Isolated rat liver cells, 1 χ 10 viable cells/ml suspen­
sion buffer (see Chapter 2, table 1) were incubated with 5 mM 
styrene in a shaking waterbath at 37 C. After different time 
intervals 1 ml aliquots were taken in triplicate and analyzed 
for GSH and styreneglycol content. In Fig. 2 the effect of 
styrene exposure on hepatocellular GSH content is illustrated. 
Depletion of GSH was only observed after phénobarbital pretreat-
ment. Therefore the animal was given phénobarbital, 75 mg/kg 
body weight i.p. daily, for three days, preceding the liver 
cell isolation. With respect to styreneglycol formation, it 
can be seen in Fig. 3 that both with and without phénobarbital 
pretreatment a time-dependent styreneglycol formation does 
occur. From this it can be concluded that, even without pheno-
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barbital induction rat liver cells are able to convert styrene 
into styrene oxide. Furthermore, they are able to detoxify this 
reactive product, both via GSH conjugation and styreneglycol 
formation. 
GSH DEPLETION AFTER ADMINISTRATION OF PARACETAMOL 
The aromatic amine paracetamol (acetaminophen, p-hydroxy-
acetanilide), widely used as an analgesic drug, can metabolically 
be toxified via oxidative N-hydroxylation and subsequent esteri-
fication of the N-hydroxy group, presumably with sulfate, to 
yield an intermediate with electrophilic properties (Fig. 4). 
R n o 
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ultimate reactive 
intermediate 
camlenl binding 
with cellular mocromolecules 
Fig. 4 Basic saheme of the metabolic activation and inactiva-
tion of paracetamol 
Although safe at therapeutic doses, the intake of large 
overdoses of this compound can lead to acute massive necrosis 
of the liver (Mitchell et al., 1973a; Prescott et al., 1971). 
Studies with rats revealed that the hepatotoxic effect is pre-
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ceded by a marked decrease in hepatic GSH content (Mitchell et 
al., 1973b). Suspensions of isolated rat hepatocytes were in-
cubated with paracetamol under identical conditions as described 
for styrene. As is shown in Fig. 5, this resulted in a concen-
tration-dependent depletion of their GSH content, which could 
be stimulated by pretreatment of the animal with phénobarbital. 
These observations indicate the ability of isolated rat liver 
cells to activate paracetamol into an electrophilic form, which 
can subsequently be detoxified by conjugation with GSH. 
G S H (nmoles/106cells) , 
τ 1 1 1 1 1 1 г 
30 60 90 120 30 60 90 120 
time(nnin ) 
Fig. 5 Hepatocellular GSH depletion after paraoetamol exposure 
A: without phénobarbital pretreatment 
В: after phénobarbital pretreatment 
Values representing one typioal experiment are means of 
three determinations. 
о control (without paracetamol), · 2 mM paracetamol 
Δ 10 Ш paracetamol 
In an attempt to demonstrate the occurrence of adverse effects, 
it was studied whether a reactive metabolite of paracetamol 
could bind covalently to cellular macromolecules. Thereto, hepa-
tocytes, 1 χ 10 viable cells/ml suspension buffer, were incu­
bated with Η paracetamol up to 10 mM final concentration (s.a. 
370 uCi/mmol) at 37 С for various times up to 120 min. Analysis 
of protein bound radioactivity was performed according to Jollow 
et al. (1973). However, no significant covalent binding was 
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observed, even when the hepatocytes were derived from phéno-
barbital pretreated rats and paracetamol was given at the 
highest applicable concentration (10 mM), i.e. without any in-
fluence on cellular viability. From in vivo experiments it was 
found that covalent binding of H-paracetamol to rat liver 
macromolecules does occur only at high doses after which liver 
GSH is depleted for more than 70% (Mitchell et al., 1973b). 
Therefore, the absence of any covalent interaction with iso-
lated rat hepatocytes might be related to its less pronounced 
GSH depletory effect on these cells. 
COVALENT ADDUCT FORMATION BY 2-ACETYLAMINOFLUORENE 
In contrast with paracetamol, the aromatic amine 2-acetyl-
ammof luorene (N-2-fluorenylacetamide, 2-AAF) , a compound that 
can also metabolically be activated via oxidative N-hydroxyla-
tion and Ν,Ο-sulfate formation, was found to bind covalently 
to hepatocellular proteins. Incubation of isolated hepatocytes, 
6 14 
1 χ 10 viable cells/ml suspension buffer with C-2-AAF (10 μΜ 
final concentration, s.a. 7.1 mCi/mmol) at 37 С resulted in a 
time-dependent formation of adducts with cellular proteins, 
which could be stimulated more than twice by pretreatment with 
phénobarbital (Fig. 6). Moreover, it was possible to differen-
tiate between adduct formation to nuclear and cytoplasmic 
proteins. As can be seen from Table 1, about 7% of the co-
valently bound radioactivity can be attributed to adduct forma-
tion with nuclear proteins. Considering that the relative 
nuclear volume amounts to about 1% of the total liver cell 
volume (Schulte-Hermann et al., 1968), a preference for nuclear 
adduct formation appears to exist in the case of 2-AAF. Further-
more, it was shown that isolated nuclei possess biotransforma-
tional capacity which could be stimulated markedly by the 
addition of a NADPH regenerating system and which resulted in 
irreversible protein binding upon exposure of isolated nuclei 
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14, Fig. в Formation of protein adducts upon incubation of 
2-AAF with isolated rat hepatoaytes. 
Analysis of protein bound radioactivity was performed 
according to Jollow et al. (1973). Protein was deter­
mined by the method of Lowry. Points are means of three 
different experiments. 
о without phénobarbital pretreatment 
• after phénobarbital pretreatment 
14 to C-2-AAF (Table 1). It сап be questioned therefore whether 
besides microsomal and cytoplasmic enzymes also nuclear enzyme 
systems may lead to the formation of electrophiles, which give 
rise to nuclear adduct formation. Since it was demonstrated 
that isolated nuclear membranes possess intrinsic biotrans-
formational activity (Jernström et al., 1976; Mukhtar et al., 
1979), it is tempting to speculate about the role of nuclear 
xenobiotic metabolism in the generation of adverse effects. 
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TABLE 1 
Covalent binding of 2-AAF to cellular and nuclear proteins 
sample nmoles/mg protein 
nmoles/10 
cell equivalents 
or nuclei 
total ce! Lis 
cytoplasma 
nuclei 
nuclei 
nuclei + NADPH** 
0.22 + 0.01 
0.24 + 0.03 
0.34 + 0.04 
0.12 + 0.02 
0.4Θ + 0.02 
0.19 
0.21 
0.015 
0.005 
0.022 
+ 0.01 
+ 0.03 
+ 0.002 
+ 0.001 
+ 0.001 
* Isolated hepatoaytes (1x10°/ml) were incubated with 10 μΜ 
14C-2-AAF (s.a. 7.1 mCi/mmol) for 80 min, 370C. After 
aolleation of 50x10° cells by gentle centri fugation, the 
cell pellet was resuspended in a minimal volume of 0.25 M 
sucrose solution, buffered with 50 mM Tris-HCl, pH 7.5, 
and homogenized with a Potter-Elvehjem apparatus. After 
destruction of the hepatoaytes, the intact nuclei were 
separated from the cytoplasmic fraction and purified ac­
cording to Blobel and Potter (1966). 
** 50x10 nuclei (5x10 /ml Tris-HCl buffered sucrose solu­
tion), isolated and purified from adult rat liver, accord­
ing to Blobel and Potter (1966), were incubated with 10 \iM 
14с-2-ААР as indicated above, with or without a NADPH 
regenerating system (1 mM MgCln, 5 mM glucose-6-phosphate, 
0.25 U/ml glucose-6-phosphate dehydrogenase, and 1.42 mM 
NADPH). 
Finally, covalently bound radioactivity was measured 
according to Jollow et al. (1973). Protein was determined 
by the method of Dowry. 
Values + S.E.M. are means of four different experiments. 
In this connection isolated liver cells may prove to be a 
powerful system in evaluating the significance of the nucleus 
in the bioactivation of chemicals under in VÌVO like condi-
tions . 
56 
REFERENCES 
Belvedere, G., J. Pachecka, L. Cantoni, E. Mussini and M. Sal-
mona, A specific gaschromatographic method for the deter-
mination of microsomal styrene mono-oxygenase and styrene 
epoxide hydratase activities, J. Chrom. 118, 387-393 (1976). 
Blobel, G. and V.R. Potter, Nuclei from rat liver: isolation 
method that combines purity with high yield. Science 154, 
1662-1665 (1966). 
Brouns, R.M.E., R.P. Bos, P.J.L. van Gemert, E.W.M. Yih-van de 
Hurk and P.Th. Henderson, Mutagenic effects of benzo(a)-
pyrene after metabolic activation by hepatic 9000 g super-
na tants or intact hepatocytes, Mutation Res. 62, 19-26 
(1979). 
Ellman, G., Tissue sulfhydryl groups, Arch. Biochem. Biophys. 
82, 70-77 (1959). 
Jernstrôm, В., H. Vadi and S. Orrenius, Formation in isolated 
rat liver microsomes and nuclei of benzo(a)pyrene meta­
bolites that bind to DNA, Cancer Res. 36, 4107-4113 (1976). 
Jollow, D.J., J.R. Mitchell, W.Z. Potter, D.C. Davis, J.R. 
Gillette and B.B. Brodie, Acetaminophen-induced hepatic 
necrosis II. Role of covalent binding in vivo, J. 
Pharmacol. Exp. Ther. 187, 194-202 (1973). 
Lowry, O.H., N.J. Rosebrough, A.L. Farr and R.J. Randall, 
Protein measurement with the Folin phenol reagent, J. Biol. 
Chem. 193, 265-275 (1951). 
Mitchell, J.R., D.J. Jollow, W.Z. Potter, D.C. Davis, J.R. 
Gillette and B.B. Brodie, Acetaminophen-induced hepatic 
necrosis I. Role of drug metabolism, J. Pharmacol. Exp. 
Ther. 187, 185-194 (1973a). 
Mitchell, J.R., D.J. Jollow, W.Z. Potter, J.R. Gillette and 
B.B. Brodie, Acetaminophen-induced hepatic necrosis IV. 
Protective role of glutathione, J. Pharmacol. Exp. Ther. 
187, 211-217 (1973b). 
Mukhtar, H., Т.Н. Elmamlouk and J.R. Bend, Epoxide hydrase and 
mixed function oxidase activities of rat liver nuclear 
membranes. Arch. Biochem. Biophys. 192, 10-21 (1979). 
Prescott, L.F., N. Wright, P. Roscoe and S.S. Brown, Plasma-
paracetamol half-life and hepatic necrosis in patients 
with paracetamol overdosage, Lancet 1_, 519-522 (1971). 
Schulte-Hermann, R., R. Thorn, I. Schlicht and W. Koransky, 
Zahl und Ploidiegrad der Zellkerne der Leber unter dem 
Einfluss körperfremder Stoffe, Naunyn-Schmiedeberg's Arch. 
Pharmakol. exp. Path. 261, 42-58 (1968). 
57 
CHAPTER 6 
MUTAGENIC EFFECTS OF BENZO(a)PYRENE 
AFTER METABOLIC ACTIVATION BY HEPATIC 
9000 g SUPERNATANTS OR INTACT 
HEPATOCYTES 
R.M.E. BROUNS, R.P. BOS, P.J.L. van GEMERT, E.W.M. YIH-
van de HURK and P.Th. HENDERSON 
Institute of Pharmacology and Toxiaology, 
University of Nijmegen, Nijmegen (The Netherlands) 
SUMMARY 
The activating capacities of isolated rat hepatocytes and 
9000 g supernatant from these cells with respect to the muta-
genic effect of benzo(a)pyrene on Salmonella typhimurium TA100 
were investigated. No mutagenicity of benzo(a)pyrene was found 
with the cell-mediated assay, unless the hepatocytes were dis-
rupted after pre-incubation with benzo(a)pyrene or the intra-
cellular glutathione content was reduced. It is suggested that 
a retention of active metabolites and an effective detoxication 
may account for the absence of mutagenic response. 
Published as a paper m Mutation Research, 62, 19-26 (1979). 
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INTRODUCTION 
During the last few years the usefulness of isolated 
hepatocyte suspensions in the study of total metabolism of 
xenobiotic compounds has been sufficiently indicated (Billings 
et al., 1977; Fry and Bridges, 1977; Grundin et al., 1975). 
Owing to the integrity of both structural and biochemical or­
ganization, biotransformational studies with intact cells ap­
proximate the situation in vivo. This is important in studies 
of the metabolism of pre-toxic compounds, such as pre-mutagens 
en pre-carcinogens, in particular in studies concerned with 
substances that are known to be activated through very compli­
cated mechanisms. An example is the multi-step activation of 
benzo(a)pyrene, extensively studied with intact liver cells 
(Burke et al., 1977; Jones et al., 1978; Vadi et al., 1976). 
It was found m these studies that certain metabolites of 
benzo(a)pyrene, which included 7,8-dihydrodiolbenzo(a)pyrene, 
the direct precursor of the postulated ultimate carcinogen, 
are selectively retained by the hepatocytes. On the other hand, 
one must also take into consideration that, in intact cells, 
the natural balance between activating and inactivating reac­
tions has been preserved. It is therefore an intriguing ques­
tion whether, in testing for benzo(a) pyrene mutagenicity by a 
short-term assay, the use of intact liver cells instead of 
microsomal preparations is reflected by an altered response. 
The present investigation deals with the potential of a 
rat hepatocyte suspension as the activating system in the 
Salmonella typhimuriwn mutagenicity test (Ames et al., 1973; 
Ames et al., 1975). Mutagenic effects of benzo(α)pyrene were 
measured in a liquid culture assay m the presence of whole 
liver-cell preparations and compared with the effects in the 
presence of microsomal fractions (9000 g supernatants) derived 
from the same cells. 
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MATERIALS AND METHODS 
Chemicals 
Collagenase type I (E.G. 3.4.24.3) was obtained from Sigma 
Chemical Co. (St. Louis, MO). Benzo(a)pyrene and W-ethylmaleimide 
were from Aldrich Europe (Beerse, Belgium). Aroclor 1254 was pur­
chased from Monsanto (St. Louis, MO). All other reagents were of 
highest purity obtainable. 
Animals 
Male Wistar rats (200-250 g) were used. Each rat received intra-
peritoneally a single dose of Aroclor 1254, a mixture of poly-
chlorinated biphenyls, in maize oil, 500 mg/kg body weight, 
5 days before the isolation of the hepatocytes. For 24 h before 
the start of the isolation procedure the animals were deprived 
of food. 
Preparation of isolated hepatooytes 
The procedure used for the isolation of rat hepatocytes was 
based on the method described by Berry and Friend (1969) and 
by Seglen (1973), except for some modifications. All techniques 
were performed under strictly sterile conditions. Anesthesia 
was given by means of an i.p. injection of sodium pentobarbital 
(60 mg/ml distilled water, 0.35 ml). 
2+ 
The pre-perfusion time with Ca -free HEPES buffer was 15 
min, followed by perfusion with a collagenase containing HEPES 
buffer (0.06% w/v collagenase) for 15 min. In both perfusions 
the rate was 25 ml/min. The crude cell suspension was treated 
according to the method of Seglen (1973), and the final pellet 
2+ 
resuspended in a Ca -containing HEPES-TES buffer solution and 
diluted to a density of 1 χ 10 viable cells/ml. This isolation 
procedure resulted in a total yield of 121 + 34 χ 10 viable 
cells. Probably owing to the pretreatment of the animals with 
Aroclor 1254, the average amount of non-viable cells as judged 
by trypan-blue exclusion was relatively high (17+3%) in com-
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parison with liver-cell preparations obtained from non-treated 
animals ( < 5%). To measure the fraction of cells that excluded 
the dye, 50 ul of the cell suspension was added to 0.5 ml trypan 
blue solution (0.12% trypan blue in saline). After 1 min the 
viability was estimated in a Burker counting chamber. 
Preparation of 9000 g supernatant from isolated hepatooytes 
Suspensions of freshly isolated hepatocytes (1 χ 10 viable 
cells/ml) were sonicated in an MSE Ultrasonic Disintegrator 
(100 W) at maximal energy for 2 χ 10 sec, with an interval of 
30 sec. During sonication the suspension was cooled in ice. 
After this treatment the solution was centrifuged at 9000 g in 
an MSE High-Speed 18 centrifuge for 20 min at 4 C. The whole 
procedure was carried out under sterile conditions. 
Measurement of intraoellular glutathione (GSH) 
The cells were harvested by centrifugation, and the pellet was 
washed once with suspension buffer. The final pellet was re-
suspended in a deproteinizing solution, containing 300 g NaCl, 
2 g EDTA (ethylene diaminetetraacetate) and 16.7 g meta-
phosphoric acid per liter. The mixture was centrifuged, and the 
GSH concentration was estimated in the supernatant by the method 
of Ellman (1959). 
Speatrophotometrio measurements 
Concentrations of cytochrome Ρ-44Θ (inclusive of P-450) were 
estimated according to the method of Estabrook et al. (1972) 
in suspensions of intact and ultrasonically disrupted cells 
(2 χ 10 cells/ml) and in microsomal preparations derived from 
these cells. 
Mutagenicity testing 
The procedure used was derived from the method described by 
Ames et al. (1973, 1975) with Salmonella typhimurium. The bac-
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terral strain used was S. typhiimrium TA100, kxndly given to us 
by Dr. Ames. The incubation conditions were as follows. In a 
shaking water-bath, 50 ml erlenmeyer flasks were incubated, 
each containing: 1 ml of hepatocyte suspension (1 χ 10 viable 
cells/ml) or 9000 g supernatant from this cell suspension; 1 ml 
of a nutrient broth culture of strain TA100 (about 5 χ 10 bac-
teria/ml) and 0.2 ml of suspension buffer. In the incubation 
with 9000 g supernatant the 0.2 ml suspension buffer contained 
an NADPH regenerating system consisting of 10 mM MgCl , 58.4 mM 
glucose-6-phosphate, glucose-6-phosphate dehydrogenase (E.G. 
1.1.1.49) at 2.θ υ/ml, and 1.77 mM NADP. After addition of 
benzo(a)pyrene (stock solutions were 20 and 2 mM benzo(a)pyrene 
in acetone) the flasks were shaken at 37 С for 1 h. Unless other­
wise mentioned, 0.1 ml samples of the incubation mixtures were 
taken in triplicate, mixed with the molten top agar and poured 
onto rainimal-agar petn dishes. After 48 h at 37 С the number 
of revertants on each petri dish was counted. 
RESULTS 
Concentration of aytoohrome P-450 enzymes 
The activity of the microsomal mono-oxygenase system is an im­
portant factor in a determination of the mutagenic effects of 
pre-mutagens, such as benzo(a)pyrene. To ascertain whether 
there was any loss in oxidative capacity during the present 
experiments, e.g. due to the manipulations by which the micro­
somal fraction was isolated from the intact liver cells, the 
total concentration of cytochromes P-450 and P-448 was estimated 
in the different preparations. Microsomal suspensions were di­
luted to a concentration equivalent to 2 χ 10 cells/ml. 
From the СО-difference spectra after reduction with sodium 
dithionite, as presented m Fig. 1, it can be seen that the 
sonicated cell suspension, the 9000 g supernatant and the micro­
somal fraction contained about the same amount of hemoproteins. 
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Fig. 1 Carbon monoxide difference spectra of cytochrome 
P-450 in sodium dithionite-reduced intact rat 
hepatocytes and subcellular preparations from 
these cells. Animals were treated with Aroclor 1254. 
The absorbance change, however, with the intact cells was sig­
nificantly lower, which may be explained by a shielding effect 
due to the compact cellular structure, or to incomplete reduc­
tion. The maxima of the CO-difference spectra were at 448 nm, 
which is in accordance with the Aroclor 1254 pretreatment of 
the rats. The total amount of cytochromes P-448 and P-450 was 
calculated to be about 2.6 nmoles/10 cells. 
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Mutagenicity test with intact cells and 9000 g supernatant 
Fig. 2 shows that incubation of benzo(a)pyrene, in concentra-
tions up to 100 yM, with the bacterial strain TA100 in the 
presence of intact liver cells, did not lead to an increased 
number of revertants. By contrast, the mutagenic properties 
emerged clearly when the incubation was carried out with the 
9000 g supernatant prepared from these cells. 
revenants per plate 
1 I 1 I 1 1 1 1 1 1 ' 
20 40 60 80 100 
benzo (a) pyrene (>jM ) 
Fig. 2 Comparison of the mutagenic activity of benzo(a)pyrene 
metabolites produced by intact hepatocytes and 9000 g 
supernatant from these cells. The activating system 
with 9000 g supernatant was supplemented with co factors 
for the microsomal mono-oxygenäse. Benzo(a)pyrene con-
centrations refer to final concentrations in the incu-
bation mixture. 
Effect of cell disruption 
It is known from the literature that reactive intermediates 
are formed during incubation of benzo(a) pyrene with isolated, 
intact hepatocytes (Burke et al., 1977; Jones et al., 1978). 
However, the possibility exists that these products are re-
tained by the cells. This may be, at least in part, an explana-
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tion for the observation that benzo(α)pyrene mutagenicity did 
not become manifest in the indicator organisms when intact 
hepatocytes were used as the activating system. 
To evaluate the significance of the release of reactive 
metabolites from the cells, the effect of cell disruption on 
mutagenicity was examined. The results are presented in Table 1. 
It appeared that disruption of the cells after pre-incubation 
with benzo(ci)pyrene, during which activation is expected to take 
place, resulted in a significantly increased number of revertants. 
Disrupted cells as such, however, were not able to give rise to 
mutagenic effects. 
TABLE 1 
The influence of hepatocellular integrity in the 
combined Salmonella/hepatocyte mutagenicity test 
Condition of the cells 
during incubation 
A. intact 
B. intact/disrupted 
C. disrupted 
Revertants 
0 yM b 
104 + 13 
113 + 10 
105 + 4 
per plate 
5 μΜ13 
96 + 2 
216 + 8 
116 + 2 
Significance 
NS 
ρ < 0.001 
NS 
α: mean values (+_ S.E.M.) are given (n=3) 
b: final concentration of benzo (a )pyrene in incubation system 
NS: not significantly different from the control experiment 
without benzo (аУругепе, (ρ > 0.05 in Student's t-test) 
A: intact cells were incubated with benzo(a)pyrene in the pres­
ence of bacteria at 37 С for 60 min. Cells remained intact 
during the whole procedure. 
B: intact cells were pre-incubated (37 С for 60 min) with 
benzo(a)pyrene in the absence of bacteria. Thereafter cells 
were disrupted by soniaation, bacteria added, and the incu­
bation continued for 60 min. 
С: sonicated cells were incubated with benzo(a)pyrene in the 
presence of bacteria at 37°С for 60 min. No NADPH-generating 
system was added. 
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Effects of glutathione depletion 
The occurrence of inactivation in addition to the activation of 
benzo a pyrene by the intact cells might be another explanation 
for the observed absence of mutagenicity in the Salmonella/ 
hepatocyte test. The role of GSH in the inactivation of toxic 
intermediates has been sufficiently indicated. For instance it 
has been reported that a decrease of intracellular GSH by the 
addition of diethyl maléate to isolated hepatocytes, resulted 
in an enhanced binding of reactive metabolites of benzo(a)-
pyrene to DMA (Burke et al., 1977). 
In the present experiments the influence of GSH depletion 
on the mutagenicity of benzo(a)pyrene in the presence of hepato-
cytes was investigated. Liver cell suspensions were treated with 
if-ethylmaleimide (0.08 mM final concentration for 5 m m ) , which 
lowered the intracellular GSH content from 30 to about 15 nmoles/ 
10 cells. Thereupon, after one washing step, the hepatocytes 
and the 9000 g supernatants from these cells were applied as an 
activating system in the mutagenicity test. It was observed that 
GSH depletion markedly increased the mutagenic effect of 
benzo(a)pyrene at a concentration of 100 PM, whereas no effect 
was found with 5 yM. In contrast with the intact cell system, 
no influence at all could be observed when the 9000 g supernatant 
was used (Fig. 3). 
DISCUSSION 
It is generally accepted that the sensitivity of short-term 
tests for detecting mutagenic compounds requiring metabolic 
activation largely depends on the properties of the activating 
system that is incorporated in the test system. In accord with 
this the present results show a marked difference in the effec-
tiveness of benzo(a)pyrene to induce revertant colonies of the 
TA100 tester strain after incubation with whole liver-cell pre-
parations and with 9000 g supernatants. 
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These 9000 g supernatants were prepared from the same pool 
of isolated cells. The drug-oxidizing potency of both liver pre­
parations was the same, as judged by measurements of Ρ-44Θ con­
centrations (Fig. 1). 
The reason for the observed difference in benzo(a)pyrene 
mutagenicity may be manifold. For instance, the cellular mem­
branes, in particular the outer cell membrane, may behave as a 
permeability barrier. Consequently, the reactive metabolites, 
especially the very short-living intermediates, do not reach 
the bacterial targets. The results presented in Table 1 are in 
favor of this concept, although they cannot fully account for 
the failure of the whole cell preparation to act as a mutagen-
activating system. 
Several studies have indicated that the interrelationship 
between the various metabolic reactions involved in biotrans­
formation, including the balance between activation and inac-
tivation, is still present in the isolated intact hepatocyte. 
Conjugation with glutathione is an important mechanism by which 
reactive intermediates are inactivated. The role of the GSH of 
the liver cells in the over-all metabolism of benzo(a) pyrene 
can be derived from the results shown in Fig. 3. It appeared 
that depletion of intracellular GSH by about 50% resulted in a 
clear-cut mutagenic effect of benzo(a)pyrene in the Salmonella/ 
hepatocyte test. However, this effect only became manifest at 
the high concentration of benzo(a)pyrene. An explanation for 
this may be that, at a benzo(a)pyrene concentration of 5 μΜ, 
the GSH level - although strongly reduced - is not a limiting 
factor in the elimination of the reactive metabolites. At much 
higher concentrations of benzo(a)pyrene, however, the GSH level 
appeared too low for an effective detoxication and apparently 
the reactive intermediates can reach high enough concentrations 
at the sites of the indicator organisms to induce a significant 
increase in mutation frequency. 
Recently Green et al. (1977) studied mutation induction 
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revertants per plate 
4 0 0 -
cdls 
2 0 0 
rh 
-H 
9 0 0 0 g sup 
ГІ1 
cells 9 0 0 0 g sup 
1 + 1 
+1 
rh 
Н-ь-
rt 
0 5 Ю0 0 5 TOO 0 5 TOO 
benzo(a) pyrene (>jM) 
Fig. 3 Effect of GSH depletion on the mutagenic activity of 
benzo(α)pyrene after metabolic activation by intact 
hepatocytes or 9000 g supernatants. Intracellular GSH 
was reduced to 50% by treatment of the cells with 
N-ethylmaleimide (0.08 mM). Mutagenicity is expressed 
as the average number of revertant colonies per plate 
(+_ S.E.M. j n=S). Benzo (a)pyrene concentrations refer 
to final concentrations in the incubation mixture. 
• untreated cells 
О cells treated with N-ethylmaleimide 
by benzo(a)pyrene using a simplified bacterial fluctuation test, 
performed with either intact liver cells or microsomal prepara­
tions. They reported that, with the intact cell test, the mini­
mal detectable level of benzo(a)pyrene was much higher than 
with microsomal activation. Although this corresponds fairly 
well with our results, it is uncertain to what extent the dif­
ferent origins of the two liver preparations used by these 
workers had contributed to the difference in mutagenic response. 
In discussions about the relationship between the carcino­
genic potency of a chemical and its potency in short-term muta-
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genicity assays, it has often been pointed out that it is not 
only microsomal activation that determines the ultimate effect. 
From this point of view the use of intact liver cells was recom­
mended instead of microsomes to supplement the test systems ги 
vitro (Bridges and Fry, 1977; Fry and Bridges, 1977). The pres­
ent results, showing significant differences in mutagenic 
potency of benzo(a)pyrene due to variations in the activating 
system, underline the usefulness of intact hepatocyte suspen­
sions as a tool for evaluating the role of total cellular 
metabolism and transport processes in relation to toxicity. 
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SUMMARY 
When suspensions of freshly isolated rat hepatocytes were 
exposed to a number of carcinogenic compounds, it was possible 
to measure an increased UDS by a rapid procedure via liquid-
scintillation counting. 
For a number of carcinogenic compounds and some of their 
non-carcinogenic structural analogues a good correlation be-
tween the carcinogenic property and the ability to induce UDS 
was demonstrable. Out of 12 carcinogenic compounds, belonging 
to several different chemical classes, 10 gave rise to an in-
creased UDS, whereas only 2 compounds, the polycyclic aromatic 
hydrocarbons benzo(a)pyrene and benz(a)anthracene, did not. 
All 4 non-carcinogenic compounds tested were negative. 
Possibly this method can be of value as a routine screen-
ing test, in combination with other short-term test systems, 
thus improving the predictive value of screening in vitro with 
respect to carcinogenicity. 
INTRODUCTION 
There are promising results showing that measurement of 
DNA excision repair might be used as a method for detecting 
carcinogenic properties of chemicals (Beikirch, 1977; Brambilla 
et al., 1978; Craddock and Henderson, 1978; Lake et al., 1978; 
Martin et al., 1978; San and Stich, 1975; Trosko and Yager, 
1974). The cell types commonly used for this purpose until 
recently, have very poor capabilities to carry out bioactiva-
tion. Because, for a great number of compounds, this bioacti-
vation step is a prerequisite for their ultimate toxic, e.g. 
mutagenic and carcinogenic, effects to occur, an artificial 
activating system had to be introduced, mostly a post-mito-
chondrial supernatant fraction of maimnalian livers. There are 
indications that, with such an activating system, the metabolic 
fate of a chemical is different from that found in vivo, so 
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that, in predicting the toxic potential of a certain compound, 
severe limitations are imposed on such a system. For instance, 
toxicity is not only determined by the extent of activation, 
because a number of detoxication reactions are also involved in 
the over-all metabolic route of a particular compound within 
the living cell. Isolated parenchymal cells from rat liver are 
able to activate pre-mutagenic and pre-carcmogenic compounds 
to their ultimate reactive forms which can result in covalent 
binding to cellular macromolecules and, in combination with a 
proper test system, can give rise to cytotoxic and mutagenic 
effects (Brouns et al., 1979; Burke et al., 1977; Fry and 
Bridges, 1977). The enzymic system responsible for the activa-
tion step, the microsomal mono-oxygenase, has been found to be 
in a functional state at least for some hours after isolation 
of the hepatocytes. 
Recently, some reports were published that demonstrate the 
induction of DMA repair in isolated rat hepatocytes by some 
carcinogenic and pre-carcinogenic compounds (Michalopoulos et 
al., 1978; Williams, 1977; Williams, 1978; Yager and Miller, 
1978). 
It is known that, in the culture of hepatocytes, a rapid 
decline in drug-metabolizing capacity occurs, visualized by a 
marked decrease in cytochrome P-450 (Michalopoulos et al., 
1976). Although some conversion of pre-carcinogenic compounds 
to forms capable of damaging DNA still occurs in cells in cul-
ture for about 24-48 h (Michalopoulos et al., 1978; Williams, 
1977), the metabolic capacity is far less than originally pres-
ent, so that it can be questioned whether this low activation 
capacity, especially with weak pre-carcinogens, will give rise 
to a detectable DMA repair. Ideally, a system should be used 
in which the activating ability resembles the actual situation 
in VÌVO as closely as possible. This can be achieved by using 
the liver cells immediately after isolation, either as a sus-
pension (Michalopoulos et al., 1978) or attached to a suitable 
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surface (Williams, 1978). 
In the present study, making use of suspensions of freshly 
isolated rat hepatocytes, we measured the incorporation of H-TdR 
into DNA by a rapid and simplified technique via liquid-scintilla-
tion counting. Some data will be presented on the repair-inducing 
properties of a number of pre-carcinogenic compounds. 
MATERIALS AND METHODS 
Chemisais 
( HJThymidine ( H-TdR), spec. act. 26 Ci/mmol, was bought from 
The Radiochemical Centre, Amersham. Collagenase type I (EC 
3.4.24.3) was obtained from Sigma Chemical Co. (St. Louis). 
Eagle's minimal essential medium including Hanks' salts was from 
Biomed (Gibco). 2-Acetylaminofluorene, biphenyl, 4-aminobiphenyl, 
2-aminobiphenyl, dimethylmtrosamine, diethylnitrosamine, di-
phenylnitrosamine, styrene oxide, p-phenylazoaniline and benzo(α)-
pyrene were all purchased from Aldnch Europe (Beerse, Belgium). 
Benzidine was from Merck. 2,3-Dimethyl-4-aminobiphenyl, benz(a)-
anthracene, 7,12-diraethylbenz(a)anthracene and 3'-methyl-4-di-
methylaminoazobenzene were from ICN Labs. 3-Methylcholanthrene 
was obtained from Koch-Light Laboratories. All other reagents 
were of analytical grade. 
Preparation of isolated rat hepatooytes 
Male wistar rats (200-250 g) were used as donors for the hepato­
cytes. 24 h before the isolation procedure was started, the rats 
were deprived of food. 
The procedure used for the isolation of the hepatocytes was 
based on the method described by Berry and Friend (1969) and by 
Seglen (1973), except for some modifications (Burke et al., 1977). 
Finally, the cells were resuspended in Eagle's minimal essential 
medium, supplemented with Hanks' salts, 10* foetal calf serum, 
streptomycin 0.01% and pemcillin-G 100 U/ml. 
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The yield of hepatocytes obtained by this procedure varied 
between 300 and 400 χ 10 cells, whereas the fraction of non­
viable cells was less than 5%, as judged by Trypan-Blue exclusion. 
To measure the fraction of cells that excluded the dye, 50 μΐ of 
the cell suspension were added to 0.5 ml Trypan-Blue solution 
(0.12% Trypan Blue in saline). Cells were counted in a Bürker 
haemocytome te r. 
Treatment of the cells with the test compound 
Erlenmeyer flasks (25 ml) were placed in a rotary shaking water-
bath (Infors WTR-1). Each flask contained 4 ml of a suspension of 
freshly isolated rat hepatocytes (10 viable cells/ml). To one 
flask, serving as a control, 40 μΐ DMSO were added under careful 
shaking, whereas the other flasks received 40 μΐ of different 
stock solutions, in DMSO, of the compounds to be tested. The 
final concentrations were 10 ,10 ,10 ,10 , 10 and 10 M. 
During incubation the cell suspensions were shaken with a rotation 
frequency of 100 rpm for 1 h at 37 С under an atmosphere of 5% CO 
and 95% О . 
Measurement of DNA repair 
Subsequently, H-TdR was added to each flask to a final concen­
tration of 1 yCi/ml, whereafter incubation was continued for 2 h. 
After this, the viability of the cells exposed to the highest 
concentration of the compound under test was determined, and at 
the same time 1 ml samples were taken from each flask in tri­
plicate and added to centrifuge tubes. 
The amount of radioactivity incorporated into DNA was deter­
mined as follows. The samples were centrifuged for 2 min at 
600 g, and the supernatants were carefully decanted. To the cell 
pellets, 0.5 ml 6 M NaSCN solution was added under vigorous shak­
ing. To achieve complete lysis of the cells, the tubes were left 
to stand for 16 h at room temperature. Subsequently, after addi­
tion of 1 ml carrier DNA solution (0.1 mg DNA/ml), macromolecules 
were precipitated by addition of 1.5 ml 20% ice-cold TCA solution 
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under vigorous shaking. After standing at 4 С for 30 min the 
tubes were centrifugad for 15 min at 3000 g. The pellet was 
washed once with 70% ethanol, once with cold 0.5 N PCA, after 
which the precipitated DNA was selectively solubilized with 1 ml 
0.5 N PCA for 60 m m at 80OC (Wanka, 1962). The tubes were then 
centrifuged for 15 min at 3000 g, and the supernatants were 
added quantitatively to scintillation vials. After addition of 
10 ml Insta-Gel (Packard) to each vial, the H radioactivity was 
measured by a Packard liquid-scintillation analyser. 
Measurement of aytoahrome P-4S0 
Cells (2 χ 10 /ml) were incubated as described. At various times, 
samples (2 ml) were taken and centnfuged at 600 g for 5 m m . The 
collected cells were resuspended in HEPES buffer to a concentra-
tion of 2 χ 10 /ml and disrupted by ultrasound in an MSE Ultra­
sonic Disintegrator. 
Cytochrome P-450 was measured spectrophotometncally in a 
Cary 118 spectrophotometer according to the method of Estabrook 
(Estabrook et al., 1972). 
Fraotionation of cell lysates on CsCl density gradients 
The procedure followed was basically that described by Shaw 
(Shaw et al., 1975). Centrifugation was carried out in an IEC 
B-60 ultracentrifuge equipped with an IEC swing-out rotor SB-405. 
The running time was 16 h, 38.000 rpm at 25 C. Fractions of 8 
drops were collected from the bottoms of the tubes. The process­
ing of the fractions was the same as that described for total 
cell lysates. 
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RESULTS 
Cytoohrome P-450 content of the hepatoaytes during incubation 
We investigated whether the microsomal mono-oxygenase, which 
catalyses the first step in the activation of many pre-carcino-
gens, remains functional during the period of incubation. The 
cytochrome P-450 concentration of the hepatocytes was measured 
at various intervals after isolation. As Fig. 1 shows, at 3 h 
after isolation only about 10-15% of the cytochrome had been in-
activated. 
Distribution of H among TCA-preaipitable materials 
When isolated rat hepatocytes 'are exposed to H-TdR, a great 
proportion of the acld-precipitable radioactivity is incorporated 
into non-DNA structures, being for the most part proteins, where-
as a minor amount of this radioactivity can be found incorporated 
into DNA as a consequence of induced DNA excision-repair after 
exposure to carcinogenic compounds (Michalopoulos et al., 1978; 
cytoctirome IJ-nlnmoles/IO6cells) 
incubation time (h) 
Fig. 1 Hepatocellular cytoohrome P-450 content during 
incubation 
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Morley and Kingdon, 1972; Yager and Miller, 1978). Therefore, 
with such a high background, due to unspecific H-TdR incorpo-
ration, any xncrease in incorporation as a consequence of UDS 
is greatly masked, as has been shown for 2-AAF (Michalopoulos 
et al., 1978). To overcome this difficulty the crude cell lysate 
was centrifuged on CsCl density gradients, by which a separation 
between DNA and protein was achieved (Michalopoulos et al., 1978; 
Shaw et al., 1975). This technique, however, is laborious. 
By using a selective final solubilization, we were able to 
eliminate this high background completely. This is visualized in 
Fig. 2. Fig. 2a shows a separation between DNA and acid-precipit-
able non-DNA structures by the CsCl gradient technique: the 
majority of the acid-precipitable radioactivity was localized 
in the upper part of the gradient. When the acid-precipitable 
material in the gradient fractions was finally treated with 
0.5 N PCA, as described in Materials and Methods, thereby ex-
clusively hydrolyzing the nucleic acids, practically all radio-
activity in the upper part of the gradient was eliminated (Fig. 
2b). 
By treatment of the acid-precipitable material, present in 
the crude cell lysates, according to this procedure, we were 
able to show a marked increase in UDS after exposure of the 
hepatocyte suspensions to 2-AAF (Fig. 3a, b; Table 1), without 
the need for any further separation on CsCl gradients. 
Measurement of cavainogen-induced DNA repair 
For a number of pre-carcinogenic compounds we measured their 
ability to evoke an increased DNA repair in suspensions of iso-
lated rat hepatocytes. In Fig. 3a, b, examples of dose-effect 
curves for some compounds are given over a 100.000-fold concen-
tration range. Table 1 shows the maximal increase in UDS for a 
number of (pre)carcinogenic compounds and some (presumably) 
non-carcinogenic structural analogues. The potential of these 
chemicals to increase UDS is compared with their carcinogenicity, 
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Fig. 2 Separation of DHA and acid-precipitabte non-DNA struc­
tures on CsCl density gradients. Incubations were carried 
out as described in Materials and Methods, except for the 
amount of 3H-TdR being 10 \iCi/ml incubation volume. Each 
gradient contained 1.25 χ 10^ lysed cells. 
a) Final solubilization was achieved by the nonselective 
solubilizer Soluene SSO (Packard), 60 min, 60oC. 
b) DM was selectively solubilized as described in 
Materials and Methods. 
and their mutagenicity as measured with the Salmonella /microsome 
assay (McCann et al., 1975). 
For 2-AAF a considerable increase in DNA repair was measured. 
This corresponds with the mutagenic and carcinogenic properties 
of this compound. Of the biphenyl compounds tested, those that 
were known to be carcinogenic were also positive in our system 
(benzidine, 4-aminobiphenyl and 2,3-dimethyl-4-aminobiphenyl) , 
whereas the non-carcinogenic biphenyl and 2-aminobiphenyl were 
79 
3 H - T d R incorporation (Vo of conlrol 1 
350
 Ί 
3 0 0 -
2 5 0 
2 0 0 
150-
100 
5 0 
3-methylcl-iolanthrene 
• ^ " 
ю
- 7
 ю
- 6 IO"5 IO" 4 IO"3 
c o n c e n t r a t i o n ( M ) 
Fig. Za Incorporation of H-TdR into DNA as a reeult of exposure 
of isolated vat hepatoaytes to different oonoentrations 
of various compounds. Values are means (+ S.E.M.) of 
measurements in triplicate. 
negative. Of the 3 nitrosamines, the carcinogenic dimethyl-
nitrosamine and diethylnitrosamine were positive, whereas the 
non-carcinogenic diphenylnitrosamine did not give rise to any 
increase in UDS. Of the carcinogenic polycyclic aromatic hydro­
carbons that were tested, benzo(a)pyrene was negative. Benz(a)-
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Fig. 3b Inaorporation of H-TdR into DNA as a result of exposure 
of isolated rat hepatooytes to different concentrations 
of various oompounds. Values are means (+_ S.E.M.) of 
measurements in triplicate. 
anthracene was negative, in contrast with its dimethyl analogue 
that was clearly positive. The two carcinogenic azo-compounds 
were both positive. 
The correlation that exists between induction of UDS and 
carcinogenicity also holds true for increased UDS and mutagenicity 
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TABLE 1 
DNA excision repair in rat hepatocyte 
suspensions induced by various chemicals 
Compound 
2-Acetylaininofluorene 
Benzidine 
Biphenyl 
4-Aminobiphenyl 
2-Aminobipheny1 
Care. 
+ 
+ 
-
+ 
-
Mut. 
+ 
+ 
-
+ 
+
w 
DNA 
repair 
increase 
+ 
+ 
-
+ 
-
%a 
167 
83 
64 
b Cone. 
(M) 
io'5 
io'5 
io'4 
2,3-Dimethyl-4-amino-
biphenyl 213 10 
Dimethylnitrosamine + 
Diethylnitrosamine + 
Diphenylnitrosamine 
86 
32 
10 
10" 
Styrene oxide 
Benzo(α)pyrene 
Benz(α)anthracene 
TjlZ-Dimethylbenzta)-
anthracene 
3-Methylcholanthrene 
ρ-Phenylazoaniline 
3'-Methyl-4-dimethyl-
aminoazobenzene 
96 
33 
124 
54 
10 
10 
10 -4 
10 
a : maximal increase as percentage over control 
b : concentration at which the maximum was reached 
+w: the compound has only a very weak mutagenic effect (McCann 
et al., 1975) 
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of the compounds tested, except for styrene oxide and 2-aminobi-
phenyl. A possible explanation for the discrepant findings about 
mutagenicity and carcinogenicity of styrene oxide is that this 
compound can be rapidly inactivated by the hepatocyte, whereas 
the inactivating capacity of bacterial systems commonly used in 
mutagenicity testing is assumed to be far less effective or even 
absent altogether. 
DISCUSSION 
The experimental results show the possibility of measuring 
increased UDS in suspensions of freshly isolated rat hepatocytes 
after incubation with (potential) alkylating agents. The method 
used is a simplification of techniques described previously 
(Michalopoulos et al., 1978; Williams, 197Θ) and may therefore 
be suitable particularly for routine measurements. As to its 
usefulness in screening programmes for predicting carcinogenic 
activity of chemicals, it has to be stressed that the main ad­
vantage of the present method is the close resemblance between 
the metabolic capacity of the hepatocyte suspension and the 
situation in vivo. Because the amount of cytochrome P-450 can 
be kept almost unchanged during the 3 h incubation period, 
suspensions of freshly isolated hepatocytes are a powerful 
system in the detection of compounds that need metabolic ac­
tivation for their mutagenic and carcinogenic effects to occur. 
Furthermore, the whole procedure, including the scintillation 
analysis, can be carried out within 48 h. Williams (1978) has 
shown that, for a number of biphenyl analogues, a good corre­
lation exists between their carcinogenicity and their ability 
to elicit UDS in isolated rat hepatocytes, attached to a sur­
face, as measured with autoradiography. The same correlation 
was demonstrated with our method. 
Interestingly, we found the polycyclic aromatic hydro­
carbons benz(a)anthracene and benzo(a)pyrene to be negative. 
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Williams had already reported a negative response for benz(a)-
anthracene (Williams, 1977). Our findings with benzo(α)pyrene, 
however, do not agree with those reported by Michalopoulos 
(Michalopoulos et al., 1978). The reason for this discrepancy is 
obscure yet. Although benzo(α)pyrene and benz(a)anthracene are 
referred to as carcinogenic in Table 1, Weisburger and Williams 
(1975) have reported that these polycyclic aromatic hydrocarbons 
are non-carcinogenic to adult rat liver. This is consistent with 
their failure to induce any UDS in our system. Possibly, this is 
a consequence of an effective inactivation of the reactive meta­
bolites formed by the isolated hepatocytes. 
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CHAPTER 8 
INHIBITION OF 
7,12-DIMETHYLBENZ(a)ANTHRACENE 
EVOKED DNA-EXCISION REPAIR IN ISOLATED 
RAT HEPATOCYTES BY SALICYLAMIDE. AN 
INDICATION OF THE INVOLVEMENT OF A 
SULFATE ESTER INTERMEDIATE IN 
CARCINOGENESIS? 
R.M.E. BROUNS, R. van DOORN, R.P. BOS and P.Th. HENDERSON 
Institute of Phaiwnacology and Toxicology, University of 
Nijmegen, Nijmegen (The Netherlands) 
It is now widely accepted that polycyclic aromatic hydro­
carbons manifest their carcinogenic activities after metabolic 
activation. The metabolic products that are suspected of initiat­
ing the malignant processes are thought to be electrophilic 
compounds capable of reacting with nucleophilic sites on cellular 
macromolecules. Several metabolites of polycyclic aromatic hydro­
carbons have been proposed as the ultimate carcinogens, including 
various arene oxides and, in particular, diolepoxides (Bayland, 
1969; Jenna and Daly, 1976; Slaga et al., 1977; Wood et al., 
1979). However, the high carcinogenic potency of some methylated 
derivatives in comparison with the non-substituted parent com­
pounds cannot yet be explained satisfactorily (Cavalieri et al., 
1978; Roth et al., 197Θ). Because oxidation of the side-chain 
Published as a short communication in Mutation Research 71, 
155-159 (1980) 
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represents a major pathway in the metabolism of methyl-substi­
tuted aromatic hydrocarbons, it is an attractive hypothesis that 
esterification of the hydroxymethyl group is responsible for the 
biological activity (Boyland and Sims, 1965; Cavalieri et al., 
1978; Flesher and Sydnor, 1971; Flesher and Tay, 1978; Rogan et 
al., 1979). The finding of Cavalieri et al. (1978) that 7-acetoxy-
methylbenz(α)anthracene was more active in initiating skin tumors 
in mice than was the hydroxymethyl compound, which in turn was 
more carcinogenic than 7-methylbenz (a)anthracene itself, strongly 
supports this idea. Further, mice treated with 6-hydroxymethyl-
benzo(a)pyrene showed much lower tumor incidence than correspond­
ing groups treated with the sulfate ester (Cavalieri et al., 1978; 
Roth et al., 1978) . 
One of the rate-limiting factors in such studies is the 
time-consuming establishment of the extent of carcinogenic potency 
of the various metabolites. Recently, we proposed that measurement 
of chemically induced DNA excision repair in suspensions of iso­
lated liver cells may be of value as a routine method in carcino­
genicity screening (Brouns et al., 1979b). Accordingly, in the 
present study, the capacity of 7,12-dimethyIbenz(a)anthracene to 
cause DNA repair synthesis m freshly isolated rat hepatocytes 
was compared with that of benz(a)anthracene. The role of sulfate 
conjugation in the bio-activation by these cells was studied in­
directly by measuring the influence of salicylamide, which is an 
effective inhibitor of sulfation in isolated hepatocytes (Anderson 
et al., 1978) . 
Suspensions of isolated rat hepatocytes were prepared from 
livers of adult male Wistar rats by the method described by Berry 
and Friend (1969) and by Seglen (1973), except for slight modi­
fications (Brouns et al., 1979a). Finally, the cells were sus­
pended in Eagle's minimal essential medium, supplemented with 
Hank's salts (Gibco), 10% fetal calf serum, streptomycin 0.01% 
and penicillin-G 100 U/ml. Cells were counted in a Burker hemo-
cytometer. The fraction of non-viable cells was less than 5%, as 
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judged by trypan-blue exclusion (Brouns et al., 1979a). 
Erlenmeyer flasks (25 ml) containing 4 ml of a suspension 
of freshly isolated hepatocytes (10 viable cells/ml) were placed 
in a rotary shaking water-bath (Infors WTR-1). To one flask, serv­
ing as a control, 40 μ 1 dimethyl sulfoxide (DMSO) were added under 
careful shaking, whereas the other flasks received 40 μΐ of differ­
ent freshly made stock solutions, in DMSO, of the compounds to be 
—6 -2 
tested. The final concentrations ranged from 10 to 10 M. 
During incubation the cell suspensions were shaken with a rotary 
frequency of 100 rpm for 1 h at 37 С under an atmosphere of 5% 
CO and 95% 0 . For the measurement of DNA repair, ( H)thymidine 
(26 Ci/nmole, Radiochemical Centre, Amersham) was added to each 
flask to a final concentration of 1 yCi/ml, whereafter incubation 
was continued for 2 h. Next, 1 ml samples were taken from each 
flask in triplicate and added to centrifuge tubes. The amount of 
radioactivity incorporated into DNA was then determined as de­
scribed previously (Brouns et al., 1979b) by a rapid procedure 
via liquid-scintillation spectrometry (Packard). 
The experimental results are summarized in Fig. la-d. From 
the concentration-effect curves presented in Fig. la it can be 
derived that 7,12-dimethylbenz(a)anthracene caused a considerable 
increase in DNA repair synthesis at a concentration of about 
-4 
10 M, whereas no positive response was observed after exposure 
of the liver cells to the non-substituted benz(a)anthracene. This 
finding corresponds well with the report that benz(a)anthracene 
is a weak carcinogen but 7,12-dimethylbenz(a)anthracene is a 
powerful and rapidly acting carcinogen (Boyland, 1969; Cavalieri 
et al., 1978). The metabolism of 7,12-dimethylbenz(a)anthracene 
differs in many respects from that of benz(a)anthracene. In 1965, 
Boyland and Sims found that the main products of metabolism of 
7,12-dimethylbenz(a)anthracene are the monohydroxymethyl deri­
vatives (Boyland and Sims, 1965). One of the possibilities sug­
gested by these authors is that the formation of hydroxymethyl 
compounds is a necessary step in the carcinogenic action of 
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Fig. 1 Effect of saliaylamide (10 M) on DNA excision repair 
in isolated rat hepatooytes after exposure of the cells 
to benz(a)anthracene (BA); 7,12-dimethylbens(a)anthracene 
(7,12-DMBA); 4~nitroquinoline-N-oxide (4-NQO); and di-
methylnitrosamine (DMN). DNA repair was measured as un­
scheduled incorporation of ('^Ή) thymidine (1 vCi/ml, 2 h) 
into DNA by a rapid procedure via liquid-scintillation 
counting (Brauns et al., 1979b). Mean values of measure­
ments in triplicate are presented here as percentages of 
controls (incubation without carcinogen). 
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methyIbenz(α)anthracene derivatives. 
Suspensions of isolated hepatocytes can perform coupled 
cytochrome Ρ-450-catalyzed reactions and conjugation reactions. 
In particular, with respect to multi-step activations of pre-
mutagenic or pre-carcinogenic compounds, intact isolated liver 
cells may, therefore, closely approximate the actual situation 
in vivo. Recently, it was reported that sulfate conjugation of 
harmol, formed from harmme in isolated hepatocytes, can be in­
hibited almost completely by salicylamide (Andersson et al. , 
1978). Accordingly, to investigate whether sulfation plays an 
essential part in the bio-activation of 7,12-dimethyIbenz(a) 
anthracene, this compound was incubated in the presence of 
-3 
salicylamide (10 M), and the influence on DNA repair was 
measured. As illustrated in Fig. lb, in the presence of salicyl­
amide, 7,12-dimethyIbenz(a)anthracene lost its ability to induce 
DNA repair synthesis in the hepatocytes. 
To rule out the possibility that salicylamide, apart from 
its inhibitory effect on sulfation, directly affects the DNA re­
pair process, or, otherwise, may interfere unspecifically with 
the formation of reactive intermediates, 2 control experiments 
were carried out. The influence of salicylamide was studied on 
the DNA repair evoked by 4-nitroquinoline-N-oxide. This compound 
requires an enzymic reduction to 4-hydroxyaminoquinoline-N-oxide, 
followed by further activation through a reaction with seryl-AMP 
(Nagao and Sugimura, 1976). Further, it was investigated whether 
salicylamide is able to counteract DNA excision repair in hepato­
cytes exposed to dimethylnitrosamine. Like 4-nitroquinoline-N-
oxide, dimethylnitrosamine is a pre-carcinogenic compound whose 
activation to ultimate electrophilic form is known to occur via 
other routes than sulfate ester formation (Magee, 1976) . The 
results presented in Fig. 1c and Id show that no direct action 
of salicylamide on DNA excision repair occurs. Hence, the con­
clusion seems valid that the failure of 7,12-dimethylbenz(a) 
anthracene to induce DNA repair in the presence of salicylamide 
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is due to an inhibition of the sulfate ester formation. Although 
there are no reasons to assume that salicylamide inhibits acety-
lation, it cannot be excluded by our results that other esters 
than sulfates are also involved in the activation of 7,12-di-
methylbenz(a)anthracene. 
This finding is in full accord with the hypothesis of 
Cavalieri and co-workers and Flesher and co-workers, that the 
carcinogenic effects of 7-methylbenz(a)anthracene and 7,12-di-
methylbenz(a)anthracene are related to their conversion to a 
hydroxymethyl derivative and subsequent formation of an ester 
bearing a good leaving group, which generates the ultimate 
electrophilic metabolite. It is an intriguing question whether 
this mechanism of activation can be extended to other carcino­
genic methyl-substituted polycyclic aromatic hydrocarbons. The 
results of the present preliminary study demonstrate that the 
use of isolated hepatocytes may be most helpful in approaches 
to this problem. 
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CHAPTER 9 
METABOLIC ACTIVATION OF 
2-ACETYLAMINOFLUORENE BY ISOLATED 
RAT LIVER CELLS: INVOLVEMENT OF 
DIFFERENT METABOLITES CAUSING DNA 
REPAIR AND BACTERIAL MUTAGENESIS. 
R.M.E. BROUNS, R.P. BOS, R. v. DOORN and P.Th. HENDERSON 
Institute of Pharmacology and Toxicology, University of 
Nijmegen, Nijmegen (The Netherlands) 
SUMMARY 
Isolated rat liver cells are able to metabolize 2-acetyl-
aminofluorene (2-AAF) to reactive species, capable of producing 
mutagenic effects in Salmonella typhimuriwn TA 1538 and evoking 
unscheduled DNA synthesis within the hepatocytes. Indications 
are presented, that these genotoxic effects are caused by dif-
ferent reactive metabolites. Mutagenesis could be blocked almost 
completely by paraoxon, an inhibitor of the de-acetylation reac-
tion, whereas induction of DNA excision repair was prevented by 
antagonizing the sulfation reaction by means of salicylamide. 
Published as a paper in Archives of Toxicology 45^ , 53-59 (1980) 
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INTRODUCTION 
Metabolic studies with 2-AAF (2-acetylaminofluorene) have 
resulted in a detailed understanding of mechanisms that are 
responsible for the carcinogenic effects of aromatic amines and 
amides. Nowadays, it is commonly accepted that 2-AAF has to be 
metabolized to a N-hydroxy-derivative before it is activated into 
an electrophilic intermediate, representing the ultimate toxic 
form. 
With respect to the great overlap between mutagenic and 
carcinogenic potency of various classes of chemicals, it is in­
triguing that in the case of 2-AAF there are indications that the 
pathways or metabolites that are responsible for covalent binding 
to tissue macromolecules are different from those that are able 
to induce mutations in Salmonella typhimuvivm ΤΑ 1538. 
Paraoxon, an inhibitor of the de-acetylation reaction, de­
creased the mutagenic potency of N-0H-2-AAF markedly (Andrews et 
al., 1978, Okuno et al., 1979; Schut et al., 1978). This finding 
and the fact that N-OH-2-AAF is highly mutagenic in the Ames-
assay without the need for an activating system (McCann et al., 
1975) , made it very plausible that the de-acetylation product, 
N-OH-2-AF, is at least in part responsible for the mutagenic 
action of 2-AAF. Under sulfation conditions in vitro, the potency 
of N-OH-2-AAF to alkylate proteins was dramatically increased, 
whereas the ability to induce mutations was decreased (Andrews 
et al-, 1978; Mulder et al., 1977). Furthermore, addition of 
nucleophiles and reducing agents such as ascorbate and NADPH 
lowered the amount of covalently bound metabolites, without 
lowering the mutagenic response (Andrews et al., 1978). 
In the present study, we investigated whether different 
pathways are responsible for the genotoxic actions of 2-AAF, 
using isolated hepatocytes from adult rats as the metabolizing 
system. The usefulness of isolated rat liver cells in studying 
biotransformation of xenobiotic compounds has been sufficiently 
indicated (Brouns et al., 1979a,· Fry et al., 1977; Michalopoulos 
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et al., 1976; Seglen, 1979; Williams, 1976). 
In the present study two different parameters were chosen 
as endpoints for genptoxicity: 1) the ability to evoke mutations 
outside the liver cells in Salmonella typhimuriwn TA 1538 and 
2) the stimulating effect on unscheduled DMA synthesis as a para-
meter of interactions at the DNA level within the hepatocytes 
(Brouns et al., 1979b; Michalopoulos, 1978; Williams, 1977). 
Using intact hepatocytes instead of subcellular fractions, we 
tried to evaluate the role of sulfation and de-acetylation with 
respect to mutagenicity and DNA repair induction. For this pur-
pose paraoxon was used as an inhibitor of the de-acetylation 
step and salicylamide as inhibitor of sulfate ester formation 
(Andersson et al., 1978). 
MATERIALS AND METHODS 
Chemisa la 
H-Thymidine ( H-TdR), s.a. 23 Ci/mmol, was bought from The 
Radiochemical Centre, Amersham, England. Collagenase type I 
(E.C. 3.4.24.3) was obtained from Sigma Chemical Co. (St. Louis, 
U.S.A.). Eagle's MEM including Hank's salts and foetal calf 
serum were from Biomed (Gibco). 2-Acetylaminofluorene, dimethyl-
nitrosamine, 4-nitroquinoline-l-oxide, paraoxon and salicylamide, 
were from Aldrich Europe (Beerse, Belgium). All other reagents 
were of the highest obtainable purity. 
Isolation of adult rat hepatooytes 
Parenchymal liver cells were isolated from adult male Wistar 
rats, under strictly sterile conditions according to the method 
as described by Berry and Friend (1969) and by Seglen (1973), 
except for some modifications (Brouns et al., 1979a). Twenty-
four hours before starting the isolation procedure the animals 
were deprived of food. 
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Mutagenicity testing 
Mutagenicity was measured according to the method of Ames (Ames 
et al./ 1975; McCann et al., 1975). The bacterial strain used 
was Salmonella typhimurium TA 1538. An overnight nutrient broth 
culture was centrifuged and the bacterial pellet was resuspended 
α 
in saline and diluted to about 5 χ 10 bacteria/ml. The incuba­
tion conditions were as follows. In a shaking water-bath 
scintillation vials were incubated, each containing 1 ml of 
hepatocyte suspension in HEPES buffer (Seglen, 1973), 2.5 χ 10 
viable cells/ml or 9000 g supernatant (1.76 + 0.12 mg protein/ml) 
derived from this cell suspension after ultrasonic treatment, 
g 
1 ml of the bacteria suspension in saline (about 5 χ 10 bacteria/ 
ml) and 0.2 ml of suspension buffer. In the incubation with 9000 g 
supernatant the 0.2 ml suspension buffer contained a NADPH-re-
generating system consisting of 10 mM MgCl_, 5Θ.4 mM glucose-6-
phosphate, glucose-6-phosphate dehydrogenase (E.G. 1.1.1.49) 
2.θ U/ml and 1.77 mM NADP. After addition of the compounds under 
test the vials were shaken at 37 С for 1 h. Then 0.5 ml samples 
of the incubation mixtures were taken in triplicate, mixed with 
3 ml of molten top-agar and poured onto minimal agar petri dishes 
(Ames et al., 1975). After 48 h at 370C the number of revertant 
colonies on each petri dish was counted. 
Meaeurement of DNA repair 
Incubation of the hepatocytes, suspended in Eagle's minimal 
essential medium, supplemented with Hank's salts, 10% foetal 
calf serum, 0.01% streptomycine and 100 U/ml penicillin G with 
the compounds under test and subsequent measurement of H-thy-
midine incorporation into DNA via liquid scintillation counting 
was essentially as described previously (Brouns et al., 1979b). 
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RESULTS 
When the intact hepatocytes were exposed to 2-AAF in the pres­
ence of the bacterial tester strain» an increased number of 
revertants was observed, as is shown in Table 1. This mutagenic 
effect was dose dependent and appeared to be in the same order 
of magnitude as the effect obtained when 9000 g supernatant from 
these cells (supplied with a NADPH regenerating system) was used 
as the activating system. 
TABLE 1 
Mutagenic effects of 2-AAF on Salmonella typhimurium 
ΤΑ 153Θ after metabolic activation by intact rat 
liver cells or 9000 g supernatant from these cells 
Treatment Revertants/plate* 
Τ
 k - ,1
 9 0 0 0
 Я 
Intact cells ^ 
supernatant 
Contro l 2 6 + 2 3 0 + 1 
2-AAF (2 χ 1 0 " 5 M) 3 6 + 2 5 5 + 4 
2-AAF ( 1 0 " 4 M) 142 + 10 140 + 11 
a: values are means of three separate experimente (*_ S.E.M.). 
In each experiment plating wae in triplioate. 
The production by the liver cells of metabolites exerting 
-4 these mutagenic effects could be completely inhibited by 10 M 
paraoxon, an efficient esterase inhibitor (see Table 2). It 
should be noted, that paraoxon itself had no deleterious effect 
on the bacteria, as was concluded from the absence of any in­
fluence on bacterial survival (data not shown). 
In Fig. 1 the effect of increasing concentrations of 2-AAF 
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TABLE 2 
Influence of paraoxon and salicylamide on mutagenic 
effects of 2-AAF on Salmonella typhimurium TA 1538 
due to metabolic activation by intact liver cells 
Treatment Revertants/platea 
Control 23 + 2 
2-AAF (10~4 M) 121 + 8 
-4 -4 
2-AAF (10 M) + paraoxon (10 M) 3 3 + 5 
2-AAF (IO*4 M) + salicylamide (10~3 M) 109 + 14 
a: values ore means of three separate experiments (+_ S.E.M.). 
In eaah experiment plating was in triplicate 
on the incorporation of Η-thymidine into DNA is shown, together 
-4 
with the influence of 10 M paraoxon on this process. It can be 
seen that in the presence of paraoxon there is still a pro­
nounced capacity of 2-AAF to induce unscheduled DNA synthesis. 
Thus, with respect to the action of paraoxon, there seems to 
exist a discrepancy between the mutagenicity and the DNA repair 
inducing capacity of 2-AAF, suggesting that different pathways 
are responsible for the respective genotoxic effects. 
As can be seen in Table 2, 1 mM salicylamide did not affect 
2-AAF mutagenicity in TA 1538 after metabolic activation by the 
liver cells. On the other hand, Η-thymidine incorporation into 
hepatocellular DNA evoked by 2-AAF, was completely reduced by 
the presence of salicylamide (Fig. 2). To exclude that this 
result is the consequence of a direct effect of salicylamide on 
the DNA repair process as such, a control experiment was done in 
which 4-nitroquinoline-l-oxide served as the alkylating species. 
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Fig. 1 Effect of 2-AAF and 2-AAF + paraoxon on H-thymidine in-
corporation in suspensions of rat liver cells. Background 
value (¿H-thymidine incorporation in the absence of 2-AAF) 
is 2950 apm/106 cells. 
3 H-TdR incorporation -
(7»above background) 
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Fig. 2 Effects of 2-AAF and 2-AAF + saliaylamide on H-thymidine 
incorporation in suspensions of rat liver cells. Back­
ground value (^Η-thymidine incorporation in the absence 
of 2-AAF) is 3000 cpm/106 cells. 
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In this case no influence of salicylamide was observed at all 
(Fig. 3). In addition, no influence of salicylamide on DNA re­
pair was observed, when the cells were exposed to the precarcino-
genic dimethylnitrosamine. There are no indications that the ac­
tivation of this compound proceeds via sulfate ester formation. 
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l o—o DMN 
1 ·—· DMN* 
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Ю
- 4
 IO-3 IO"2 
concentration ( M ) 
Fig. 3 Influenae of salicylamide on 3Η-thymidine 
incorporation in liver celle визрепегопв, exposed to 
4-nitroquinoline-l-oxide (4-Щ0) and dimethylnitroeamine 
(DMN). Background value (^Η-thymidine incorporation in 
the absence of 4-Щ0 or DMN) is 3000 apm/10° cells. 
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DISCUSSION 
The observation, that the mutagenic response, due to activation 
by intact cells or 9000 g supernatant from these cells is in the 
same order of magnitude, indicates that metabolites, that are 
mutagenic to Salmonella typhimurium TA 1538 are formed within 
the hepatocyte and are stable enough to leave the cells and 
enter the bacteria. 
Paraoxon completely prevented the effect of 2-AAF in the 
Salmonella mutagenesis test with intact hepatocytes as the ac-
tivating system. This is in agreement with the results from in 
vitro experiments (Andrews et al., 1978; Okuno et al., 1979; 
Schut et al., 1978). Paraoxon, however, at the same concentration 
-4 (10 M) hardly affected the 2-AAF evoked DNA repair synthesis in 
the liver cells. The reversed was found with salicylamide. This 
compound completely prevented the induction of DNA repair in the 
hepatocytes by 2-AAF, without influencing the mutagenic effect of 
2-AAF in the bacteria. Paraoxon and salicylamide can be considered 
as inhibitors of de-acetylation and sulfation of N-hydroxylated 
2-AAF, respectively. There are many reliable indications that 
these enzymatic reactions are both essential steps in the genera-
tion of different species of reactive intermediates. Our findings 
suggest that the electrophilic metabolite(s) that are responsible 
for the genotoxic effect within the hepatocyte and those causing 
bacterial mutagenesis are not the same. 
These results are in accordance with the previous findings 
from in vitro studies (Andrews et al., 1978), which suggest an 
inverse relationship between mutagenicity of N-OH-2-AAF on Sal-
monella and the covalent binding. In stead of measuring covalent 
binding to tissue macromolecules, mostly proteins, we used the 
induction of one of the defense mechanisms of the cell, DNA re-
pair, as a parameter of toxicity at the DNA level. 
One of the ultimate carcinogenic metabolites of 2-AAF is 
believed to be the N-O-sulfate ester (DeBaun et al., 1970). We 
observed that inhibition of sulfate formation caused a strong 
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reduction of the capability of 2-AAF to evoke DNA repair. How-
ever, mutagenicity was not influenced. This suggests that sulfa-
tion of N-0H-2-AAF gives rise to metabolites that are able to 
alkylate DNA in their immediate environment without being 
detectable as mutagens in the Salmonella system. 
Possibly, introduction of the hydrophilic sulfate group 
makes the membrane passage of the metabolites very difficult. 
Another explanation may be that the electrophiles derived from 
the sulfates are short-lived and/or so reactive, that they react 
only with nucleophilic groups within the liver cells and cannot 
reach the critical target molecules of the bacteria. On the 
other hand, the total disappearance of the mutagenic effect of 
2-AAF when the de-acetylation is blocked by paraoxon, suggests 
that the mutagenic metabolite, which is capable of passing 
through the cell membrane and penetrating the bacteria, is 
N-OH-2-AF or a derivative thereof. 
Since from these findings it may be concluded that meta-
bolites of 2-AAF which are mutagenic to Salmonella typhimirium 
seem to be different from those giving rise to covalent binding 
or DNA repair, one wonders which type of metabolite does repre-
sent the actual carcinogenic species. It has widely been accepted 
that carcinogenic properties of chemicals can be detected by 
means of short-term mutagenicity tests. However, our results 
which are in accordance with the in vitro findings of Andrews 
et al. (1978), may suggest that bacterial mutagenicity testing 
cannot be applied unlimitedly to all classes of carcinogens. 
Measurement of DNA repair in isolated liver cells may add to an 
improvement of the predictive value of short-term carcinogenicity 
testing. 
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CHAPTER 10 
METABOLIC ACTIVATION OF 
2-AMINOFLUORENE BY ISOLATED RAT LIVER 
CELLS THROUGH DIFFERENT PATHWAYS 
LEADING TO HEPATOCELLULAR DNA REPAIR 
AND BACTERIAL MUTAGENESIS 
R.M.E. BROUNS, R. VAN DOORN, R.P. BOS, L.J.S. MULLENERS and 
P.Th. HENDERSON 
Institute of Pharmaoology and Toxicology, University of 
Nijmegen, Nijmegen (The Netherlande) 
SUMMARY 
The aromatic amine 2-aminofluorene (2-AF) is metabolised 
by isolated rat liver cells to reactive species, thereby caus­
ing mutagenic effects in Salmonella typhimurium ΤΑ 1538 and 
evoking DNA excision repair within the liver cells. The path­
way leading to the production of metabolites mutagenic in 
Salmonella is likely to proceed via direct N-hydroxylation of 
2-AF to N-hydroicy-2-aminofluorene (N-OH-2-AF) . On the other 
hand, the formation of intermediates giving rise to hepato­
cellular DNA repair is shown to depend upon N-acetylation of 
2-AF to 2-acetylaminofluorene (2-AAF), whereas a subsequent 
conjugation reaction, most likely to be sulfate ester formation, 
is also essentially involved. 
Published as a paper in Toxicology !£, 67-75 (1981) 
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INTRODUCTION 
Nowadays it is generally accepted that carcinogenic 
aromatic amines and amides require N-hydroxylation as an es­
sential step in their biotransformation to electrophilic 
species (Cramer et al., 1960,- Miller et al., 1961; Miller and 
Miller, 1969). Furthermore, evidence has been presented that 
additional pathways are involved in producing ultimate reactive 
intermediates. 
In case of N-hydroxy-2-acetylaminofluorene (N-OH-2-AAF) 
both a sulfotransferase (DeBaun et al., 1970a, b,- Miller and 
Miller, 1969) and a Ν,Ο-acyltransferase (Bartsch et al., 1972, 
1973; King, 1974) catalyzed reaction have been postulated as 
being of major importance in this respect, whereas a glucuronyl-
transferase mediated reaction has also been reported (Irving and 
Wiseman Jr., 1972; Poupko et al., 1979). 
Despite the good sensitivity of the SalmonelZa/micioscme 
mutagenesis assay in predicting carcinogenic activity in gen­
eral, some doubt has raised whether in the case of the aromatic 
amines and amides mutagenic effects in the Salmonella system 
represent the formation of the actual carcinogenic inter-
mediate(s) (Andrews et al., 1978; Brouns et al., 1980; Sakai 
et al., 1978; Weeks et al., 1978). It was found that a para-
oxon sensitive deacetylatlon step was crucially involved in 
the mutagenic activation of N-OH-2-AAF (Andrews et al., 1978; 
Okuno et al., 1979; Schut et al., 1978), resulting in the 
formation of N-OH-2-AF, which is mutagenic per se, or can be 
further converted into mutagenic products, e.g. 2-nitroso-
fluorene. However, the ability of N-OH-2-AAF to give adducts 
with proteins and nucleic acids was shown to depend upon sulfo­
transferase (DeBaun et al., 1970a; Mulder et al., 1977) or 
Ν,Ο-acyltransferase (Weeks et al., 1978) activity. 
In a previous paper (Brouns et al., 1980) we reported 
that metabolic activation of 2-AAF by isolated rat liver cells 
to metabolites mutagenic to Salmonella typhirmœium TA 1538 
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proceeds mainly via a paraoxon sensitive deacetylation reaction. 
On the other hand, the formation of DNA-modifying metabolites as 
measured from the occurrence of enhanced DNA repair activities, 
was strongly antagonized by salicylamide, an effective inhibitor 
of sulfate ester formation (Andersson et al., 197Θ). In the 
present study it was investigated whether mutagenic activation 
of 2-AF by isolated rat liver cells proceeds via pathways, dif­
ferent from those producing DNA damaging metabolites. In parti­
cular the role of N-acetylation in this respect was evaluated. 
MATERIALS AND METHODS 
Chemiaala 
H-thymidine ( H-TdR), s.a. 23 Ci/mmol, was purchased from The 
Radiochemical Centre, Amersham, England; Collagenase type I (EC 
3.4.24.3) was obtained from Sigma Chemical Co. (St. Louis, USA). 
Eagle's MEM including Hank's salts, and foetal calf serum were 
from Biomed (Gibco). 2-AF, 2-AAF, 4-nitroquinoline-l-oxide 
(4-NQO), paraoxon, salicylamide and harmine-HCl were from 
Aldrich Europe (Beerse, Belgium). All other reagents were of 
the highest obtainable purity. 
Preparation of isolated rat liver cells 
Parenchymal liver cells were isolated from adult male Wistar 
rats under strictly sterile conditions. The method applied was 
basically the same as the one described by Berry and Friend 
(1969) and by Seglen (1973), except for some modifications 
(Brouns et al., 1979a). Twentyfour hours before the isolation 
procedure was started the animals were deprived of food. 
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Mutageniüity teeting 
Measurement of mutagenic effects was based upon the method of 
Ames (Ames et al., 1975), with some modifications. The bacterial 
tester strain was Salmonella typhùmtrium ΤΑ 153Θ. An overnight 
nutrient broth culture was centrifugea and the bacterial pellet 
was resuspended in saline and diluted to about 5 χ 10° bacteria/ 
ml. The incubation conditions were as follows: in a shaking 
water bath scintillation vials were gently shaken. Each vial 
contained 1 ml of a suspension of freshly isolated rat hepato-
cytes in HEPES buffer (Seglen), 2.5 χ 10 viable cells/ml, and 
1 ml of the bacteria suspension in saline. The compounds under 
test were added as a concentrated solution: 2-AAF, 2-AF and 
paraoxon in DMSO; harmine-HCl in saline; and salicylamide in 
ethanol. When ethanol was used as solvent, the incubation vials 
received 1 ul of test compound/ml of incubation volume. Other­
wise 10 yl/ml were added. Subsequently the vials were shaken at 
37 С for 1 h. Then 0.5 ml samples of the incubation mixtures 
were taken in triplicate, mixed with 3 ml of molten topagar and 
poured onto minimal agar petri dishes. After 48 h at 37 С the 
number of colonies reverted to histidine prototrophy on each 
disk was counted. 
Measurement of DNA ехаівіоп repair 
Incubation of the hepatocytes suspended in Eagle's MEM, supple­
mented with Hank's salts, 10% foetal calf serum, 0.01% strepto­
mycin and 100 U/ml penicillin G with the compounds to be inves­
tigated and subsequent measurement of H-TdR incorporation into 
DNA via liquid scintillation counting was essentially as de­
scribed previously (Brouns et al., 1973b). 
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RESULTS 
The aromatic amines 2-AF and 2-AAF were metabolized to 
mutagenic species by the hepatocytes in the presence of the 
tester bacteria, as is shown in Table I. For both substrates 
the number of revertants was concentration-dependent. It should 
be noted that the mutagenic response upon incubation of the 
bacteria with the substrates in the absence of hepatocytes dif­
fered only marginally from the spontaneous reversion frequency. 
TABLE I 
The influence of paraoxon, harmine and salicylamide 
on the mutagenic activity of 2-AF and 2-AAF after 
metabolic activation by isolated rat liver cells 
Cone. 
Cone. 
2-AF 
20 
100 
500 
2-AAF 
20 
100 
500 
(PM) 
(μΜ) 
Control 
113+ 18 
693+ 66 
1415+120 
16+ θ 
78+ 14 
391+ 45 
+Paraoxon 
(10~4 M) 
108+ 22 
671+116 
1337+ 55 
18+ 9 
12+ Э 
16+ 14 
+Harmine 
(10"4 M) 
158+ 14 
536+ 56 
1148+139 
22+ 12 
98+ 11 
399+ 31 
+Salicyl-
amide 
(10° M) 
108+16 
596+28 
1392+85 
10+ 7 
68+19 
324+23 
Values represent revertants of Salmonella typhimurium TA 1538 
per plate, oorreated for background reversion frequency, and 
are means +_ S.E.M. of 3 different experiments. In each experi­
ment plating was done in triplicate. 
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In the case of 2-AAF the observed mutagenic effects could 
be greatly decreased by the microsomal deacetylase inhibitor 
-4 
paraoxon (10 M final cone). However, paraoxon did not in­
fluence the mutagenicity of 2-AF. This finding suggests that 
N-acetyltransferase catalyzed conversion of 2-AF into 2-AAF is 
not involved in the generation of metabolites mutagenic in our 
system. This idea is further supported by the observation that 
2-AF mediated mutagenicity is not altered by the addition of 
harmine, an effective inhibitor of N-acetyltransferase (Wright 
et al., 1979). 
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Fig. 1 Effect of paraoxon, harmine and salicylamide on H-TdR 
incorporation in suspensions of rat liver cells, ex­
posed to 2-AF. Background value (incorporation of 
radioactivity without 2-AF) is 2000 cpm/10° cells 
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When suspensions of hepatocytes were incubated with 2-AF 
and 2-AAF in the presence of H-TdR an increased incorporation 
of radioactivity into DNA could be measured due to the occur-
-4 
rence of DNA excision repair. Addition of harmine (10 M) to 
the incubation system resulted in a substantial decrease in 2-AF 
evoked DNA repair (Fig. 1), whereas the harmine effect in the 
case of 2-AAF was much less pronounced (Fig. 2). This observa­
tion indicates that the influence of harmine on the 2-AF induced 
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Fig. 2 Effect of paraoxon, harmine and aalicylamide on H-TdR 
incorporation in suspensions of rat liver cells, ex­
posed to 2-AAF. Background value (incorporation of 
radioactivity without 2-AAF) is 3000 apm/106 cells 
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DNA repair was not due to any effect on the repair process as 
such, as is also illustrated by the absence of any influence of 
harmine on the 4-NQO evoked DNA repair (Fig. 3). These findings 
suggest that N-acetylation of 2-AF is essential in the produc-
tion of intermediates giving rise to DMA damage. 
The influence of paraoxon on the hepatocellular DNA repair 
due to 2-AF and 2-AAF exposure was also studied. With 2-AF as 
test substance, paraoxon did not have any effect at all (Fig. 
1). Also in the case of 2-AAF paraoxon did not drastically alter 
the H-TdR incorporation (Fig. 2), as has also previously been 
^H-TdR incorporation 
1 % ¿bow backgraund) 
160 
1 2 0 -
Fig. 3 Effect of harmine on H-TdR incorporation in suspen-
sions of rat liver cells, exposed to 4-Щ0. Background 
value (incorporation of radioactivity in the absence 
of 4-NQO) is 1800 срт/10в cells 
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reported (Brouns et al., 1980). 
It was shown earlier (Brouns et al., 1980) that salicyl-
amide blocks the 2-AAF evoked DMA excision repair completely. 
The same phenomenon was observed with 2-AF as a substrate (Fig. 
1), indicating that for both aromatic amines the same pathway, 
likely to be sulfate ester formation, could lead to the genera-
tion of DNA modifying metabolites. On the other hand, bacterial 
mutagenesis mediated by 2-AF and 2-AAF in the presence of the 
isolated hepatocytes was left unaffected by salicylamide. 
DISCUSSION 
The results presented in this paper demonstrate the ability 
of isolated rat liver cells to activate 2-AF to metabolites giv-
ing both rise to mutagenic effects m Salmonella typhimurium 
TA 1538 and hepatocellular DNA repair. The data presented are 
consistent with the hypothetical scheme, as is illustrated in 
Fig. 4. 
0û0N w 0Q0r^- 0u0sb 
OOQV OûOr 
рагаде of cell mertove DNA adduci formation 
. wrthci hepatocyte 
I I 
mutagene to Sahrmella ' 
hepahœuula· DNA-rqur 
Fig. 4 Tentative scheme for the activation of 2-AF by vat 
hepatocytes to carcinogenic and mutagenic metabolites 
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Inhibition of the N-acetylation reaction (pathway A) by 
means of the N-acetyltransferase inhibitor harmine resulted in 
a decreased DNA repair effect, whereas mutagenicity was unaf­
fected. Further it was found that treatment of the cells with 
the carboxyesterase/amidase inhibitor paraoxon had no effect on 
2-AF mutagenicity. However, the mutagenic potency of 2-AAF was 
strongly reduced by paraoxon. These data are in favour of the 
concept that mutagenic activation of 2-AF does proceed directly 
via N-hydroxylation, without the need for prior N-acetylation, 
whereas, in the case of 2-AAF, deacetylation possibly either 
via pathway В or D is essentially involved in this respect. 
On the other hand, since harmine treatment markedly reduced 
the amount of H-TdR incorporation into hepatocellular DNA due 
to 2-AF exposure, without showing this effect in the case of 
2-AAF, it can be concluded that N-acetylation of 2-AF to 2-AAF 
is involved in the bioactivation of 2-AF resulting in an inter­
action with hepatocellular DNA. Furthermore, salicylamide com­
pletely prevented the occurrence of DNA repair with both 2-AF 
and 2-AAF. It should be mentioned that salicylamide did not 
affect the incorporation of H-TdR evoked by the directly act­
ing agent 4-NQO, as was reported previously (Brouns et al., 
1980). Obviously, both compounds share a common pathway, most 
likely sulfate ester formation (pathway C), in the generation 
of DNA modifying intermediates, leading to DNA repair. These 
data are in accordance with the hypothesis that 2-AF is first 
metabolized via N-acetylation to 2-AAF, which in turn has to 
be N-hydroxylated and subsequently activated via N,0-sulfate 
ester formation to yield the ultimate reactive species, giving 
rise to DNA repair within the liver cell. 
Recently, it was reported that a good correlation exists 
between carcinogenicity of compounds and their ability to evoke 
unscheduled DNA synthesis within hepatocytes (Brouns et al., 
1979b; Michalopoulos et al., 1978; Williams, 1977). The iso­
lated hepatocyte might thus be a suitable biological system 
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for the prediction of carcinogenic properties of chemicals. 
One of the great advantages of these cells in evaluating the 
potential harmful effects of xenobiotics is offered by their 
ability to metabolize these compounds in a way resembling the 
situation in vivo. In addition, toxic effects due to formation 
of reactive intermediates can be detected in the same liver 
cells. 
Despite the high sensitivity of bacterial mutagenesis test 
systems with respect to the prediction of genotoxic properties, 
the possibility that for certain classes of compounds, e.g. 
aromatic amines, mutagenicity and carcinogenicity do not share 
the same metabolic events, implicates the almost imperative 
use of additional studies to understand the relationship between 
biotransformation and the initiation of cancer. 
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SUMMARY 
Isolated rat liver cells were shown to metabolize the 
aromatic amine benzidine to reactive products which are muta-
genic to Salmonella typhirmœiim ΤΑ 1538 and which give rise to 
DNA excision repair within the liver cells. Intact rat liver 
cells are shown to be more active in the formation of mutagenic 
metabolites than 9000 g supernatant from these cells. Data are 
presented which are in favour of the role of N-acetylation in 
this respect. Furthermore, indications are presented that a 
sulfation reaction is involved in the generation of DNA modify­
ing metabolites, whereas formation of mutagenic products is 
likely to proceed via deacetylation and/or Ν,Ο-acyltransfer. 
Finally, data are given about the extra hepatocellular appear­
ance of premutagenic metabolites which are more prone to meta­
bolic activation by additional metabolic factors in the Salmo­
nella assay than benzidine itself. The impact of these observa­
tions on the estimation of the genotoxic potential of benzidine 
will be discussed. 
Submitted for publication 
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INTRODUCTION 
The aromatic amine benzidine was epidemiologically shown 
to be a human carcinogen, producing urinary bladder tumors. In 
experimental animals it also produces tumors, for example in 
the liver of mice and hamsters, and in the liver, intestine and 
mammary gland of rats (Haley, 1975). 
During the last two decades much information has become avail­
able about the mechanisms that can be held responsible for the 
carcinogenic effects of arylamines and arylamides. An essential 
initial step in the bioactivation of aromatic amines and amides 
is claimed to be N-hydroxylation, mediated by mono-oxygenases, 
mainly localized in the endoplasmic reticulum of the liver 
(Cramer et al., 1960; Miller et al., 1961; Miller and Miller, 
1969). For the generation of the ultimate reactive intermediates 
that bind covalently to cellular constituents and that are be­
lieved to represent the actual carcinogens, transferase cata­
lyzed reactions appear to be implicated. In this respect sulfo-
transferase (DeBaun et al., 1970a,b; Miller and Miller, 1969), 
Ν,Ο-acyltransferase (Bartsch et al., 1972, 1973; King, 1974), 
and glucuronyltransferase (Irving and Wiseman, 1971) catalyzed 
conjugation of the N-hydroxy moiety have been postulated. Only 
recently, in vitro studies showed that metabolic activation of 
benzidine can proceed via N-acetylation and subsequent N-hydro-
xylation leading to the formation of N-hydroxy-N,N'-diacetyl-
benzidine (Morton et al., 1979). Furthermore, the role of both 
sulfotransferase and Ν,Ο-acyltransferase in the formation of 
metabolites leading to adduct formation and mutations have been 
indicated (Morton et al., 1979, 1980). Recently, we showed that 
the isolalied rat hepatocyte, representing a morphological and 
biochemical entity, is able to metabolize the aromatic amines 
2-aminofluorene and 2-acetylaminofluorene to genotoxic products, 
causing DNA repair effects within the liver cell and mutations 
in Salmonella typhimuriim (Brouns et al., 1980, 1981). In the 
present study we investigated the role of hepatocellular meta-
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bolism of benzidine in the formation of reactive metabolites, 
using DNA repair effects within the liver cell and bacterial 
mutagenicity as parameters for genotoxicity. 
MATERIALS AND METHODS 
Chemicals 
3 3 
H-Thymldine ( H-TdR), s.a. 23 Ci/mmol was purchased from the 
Radiochemical Centre (Amersham, England). Collagenase type I 
(E.G. 3.4.24.3) was bought from Sigma Chemical Co. (St. Louis, 
U.S.A.). Eagle's Minimal Essential Medium (MEM), including 
Hank's salts, and foetal calf serum were obtained from Biomed 
(Gibco). Benzidine, harmine-HCl, salicylamide and 4-aminoazo-
benzene (= p-phenylazoaniline) were from Aldrich Europe (Beerse, 
Belgium). All other reagents, obtained from different sources, 
were of the highest purity obtainable. 
Isolation of rat liver cells 
Parenchymal liver cells were isolated from adult male Wistar 
rats under sterile conditions by means of a collagenase per-
fusion method (Berry and Friend, 1969; Seglen, 1973). Twenty 
four hours before the isolation procedure was started the 
animals were deprived of food. 
Measurement of hepatocellular DNA repair 
Incubation of the hepatocytes, suspended in Eagle's MEM, 
supplemented with Hank's salts, 10% foetal calf serum, 0.01% 
streptomycine and 100 U/ml penicillin G with the compounds to 
3 
be investigated and subsequent measurement of H-TdR incorpo-
ration into DNA via liquid scintillation counting was essentially 
as described previously (Brouns et al., 1979). 
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Measurement of mutagenicity 
Experiments on mutagenicity were basically performed according 
to the method described by Ames et al. (1975). Salmonella 
typhimurium TA 1538 was used as bacterial tester strain. There­
to, an overnight nutrient broth culture was centrifuged and the 
bacterial pellet was resuspended in saline at a concentration 
α 
of approximately 5 χ 10 bacteria/ml. The experimental procedure 
was as follows : a suspension of liver cells in HEPES buffer 
(Seglen), 2.5 χ 10 viable cells/ml, was added to 3 ml of molten 
topagar, together with the compounds under test and the bacteria 
and - when indicated - supplemented with a postmitochondrial 
fraction from rat liver. In the case of pre-incubation (see 
below), cell free supernatant was added to the topagar together 
with the test compounds, bacteria and different subcellular 
liver fractions as additional activating system. Detailed ex­
perimental conditions will be given in the legends. The topagars 
supplemented with the different components were poured onto 
minimal agar petri dishes. After 48 hours at 37 С the number of 
histidine prototrophic colonies was counted on each disk. 
Pre-inaubation of liver cells 
Suspensions of freshly isolated hepatocytes, 2.5 χ 10 viable 
cells/ml, were incubated in 50 ml Erlenmeyer flasks in a shaking 
waterbath (Infors WTRl) at 37 С together with the compound under 
test, added as a concentrated solution in dimethylsulphoxide 
(DMSO). The final amount of DMSO did not exceed 10 μΐ/ml incuba­
tion volume. After various time intervals aliquote of 2 ml were 
taken and centrifuged immediately. Next 0.5 ml aliquots of the 
supernatant were added to the molten topagar together with the 
other components. Detailed descriptions are given in the legends. 
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RESULTS 
Mutagenic effects after· aeti-vation of benzidine by hepatoaytea 
and hepatocellulop 9000 g supernatant 
When intact rat liver cells were used as metabolizing system, 
it was found that benzidine could be activated to metabolites 
exerting mutagenic effects in Salmonella typhimurium TA 1538. 
The mutagenicity as a function of the benzidine concentration 
is presented in Fig. 1. When, instead of intact cells, 9000 g 
supernatant of the same cells prepared by ultrasonic treatment 
as described previously (Brouns et al., 1979a), was given as a 
metabolizing component, fortified with an external NADPH re­
generating system, mutagenicity was considerably lower. 
revenants ΤΑ153β/plate 
200 т 
1 6 0 -
-ι 1 1 1 1 r 
200 400 600 
benzidine cone (;uM) 
Fig. 1 Mutagenic activation of benzidine by intact rat liver 
cells ( о ) or 9000 g supernatant from these cells 
after ultrasonic treatment ( · ) . To 3 ml of molten 
topagar were added: 0.5 ml cell suspension 2.5 χ 10 
viable cells/ml) or 0.5 ml 9000 g supernatant, forti­
fied with a NADPH regenerating system, consisting of 
8mM МдСІ2, 4 mM NADP, 5 mM gluoose-6-phosphate and 
2.8 U/ml glucose-6-phosphate dehydrogenase, 0.1 ml of 
bacteria (TA 1538) suspended in saline and 41 \il of 
different freshly prepared solutions of benzidine in 
DMS0. Values (revertants/plate), representing one typi­
cal experiment, are means of determinations in triplicate. 
124 
Effect of modified hepatoaellular N-aoetylation and sulfation 
The involvement of N-acetyltransferase and sulfotransferase 
catalyzed reactions in the metabolic activation of benzidine 
was demonstrated by Morton et al. (1979, 1980). It was studied 
now whether liver cell mediated mutagenicity of benzidine could 
be affected by modifying these transferase catalyzed reactions. 
For that purpose harmine was used to inhibit N-acetylation 
(Wright et al., 1979), whereas the sulfation reaction was an­
tagonized by salicylamide (ftndersson et al., 1978). Also the 
effect of supplementation with p-nitrophenylsulfate (pNPS) 
and 3'5'-adenosine diphosphate (PAP), resulting in the forma­
tion of 3'-phosphoadenosine-5'-phosphosulfate (PAPS), a co-
factor for the sulfation reaction, was studied. The influence 
of these modifying agents on the activation of benzidine by 
isolated rat liver cells to mutagenic species is presented in 
Fig. 2. Mutagenicity was considerably reduced by harmine 
(500 μΜ), whereas inhibition of the sulfation reaction by 
salicylamide (1 mM) had no influence. Stimulation of the sul­
fate conjugation even resulted in a marked decrease of muta­
genicity. It should be remarked that none of these treatments 
had any effect on bacterial survival, nor did they reduce 
hepatocellular viability. 
Influenae of pre-inoubation and additional metabolic activation 
on mutagenic potential of benzidine 
Besides the observation that upon incubation of benzidine with 
rat liver cells metabolic products are formed that exert direct 
mutagenic effects in Salmonella typhimurium, evidence was ob­
tained that liver cell mediated metabolism of benzidine gives 
rise to the formation of products that are not mutagenic per se 
but need an additional activation to become mutagenic. The ex­
perimental approach was based on a pre-incubation of benzidine 
with liver cells, whereafter the extracellular medium was sub­
jected to an additional metabolic activation according to the 
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revenants TA1538/ plate 
200 400 600 
benzidine cone (^ jM ) 
Fig. 2 Mutagenic! activation of benzidine by intaat rat liver 
cells in the presence of harmine, 500 vM ( A )· 
saliaylamide, 1 mM ( D ) ; PAP, 20 \iM + pNPS, 10 mM 
( · ) ; Control ( о ) . To 3 ml of molten topagar 
were added: 0.5 ml cell suspension (2.5 χ 10^ viable 
cells /ml ) , 0.1 ml bacteria (ТА 1538) suspended in 
saline and the compounds under test, added as concen­
trated solutions in ethanol (saliaylamide), DMSO (4-
aminoazobenzene) or saline (hamine-HCl, PAP + pNPS) 
to reach the final concentrations in the topagar as 
indicated. Values (revertants/plate), representing 
one typical experiment, are means of determinations 
in triplicate. 
standard Ames assay with rat liver 9000 g supernatant. In Fig. 
3 the effect of pre-incubation with rat liver cells on the 
mutagenic activation by rat liver 9000 g supernatant is 
visualized. Due to pre-incubation with intact cells a fourfold 
increase in the amount of revertant colonies was found. Further­
more, the observed difference in mutagenicity was found to be 
dependent upon the pre-incubation time, as illustrated in Fig. 
4. In order to obtain information about the nature of the pre-
mutagenic products released by the hepatocytes, it was investi-
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r e v e n a n t s T A 1 5 3 8 / p l a t e 
1200 
1000 
8 0 0 -
600 
4 0 0 -
200 
200 A00 600 
benzidine cone (^иМ) 
Fig. 3 Uutagenia aativation of benzidine by hepatic 9000 g 
supernatant after pre-inaubation with ( о ) or 
without ( · ) intact rat liver cells. 
Benzidine (final concentration on the axis) was pre-
incubated either with or without rat liver cells for 
60 min as indicated in "Materials and Methods". After 
removal of the cells by centrifugation, 0.5 ml of the 
cell free supernatant was added to 3 ml of molten top-
agar, together with 0.5 ml 9000 g si^pematant from 
liver of phénobarbital pretreated rats, corresponding 
to 12.5 mg of liver tissue, fortified with a MDPH 
regenerating system (see legend Fig. 1) and 0.1 ml 
of bacteria (TA 1538) suspended in saline. 
Values (revertants/plate), representing one typical 
experiment, are means of determinations in triplicate. 
gated which metabolic factors were required for the additional 
mutagenic activation. As can be seen from Table 1, a combined 
action of both microsomes and cytosol was essential in this 
respect, whereas also NADPH was required. These findings sug-
gest the involvement of a microsomal oxidative step, followed 
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reverlantsTA1538/plate 
1200 т 
1000-
Θ00-
600-
400-
200 
АО 60 
incubation time (min) 
Fig. 4 Mutagenic activation of benzidine by hepatic 9000 g 
supernatant after various pre-inaubaticm times with 
( о ) or without ( · ) rat liver cells. 
Benzidine (S00 \¡M final concentration) was pre-incu-
bated either with or without rat liver cells for 
various times. Samples were immediately cooled on ioe, 
quickly centrifugea in the cold, after which 0.5 ml of 
the cell free supernatant was added to 3 ml of molten 
topagar. The remaining procedure was as described for 
Fig. 3. Values ('revertants/plate), representing one 
typical experiment, are means of determinations in 
triplicate. 
by either a sulfotransferase or Ν,Ο-acyltransferase catalyzed 
reaction (Morton et al., 1979, 19Θ0) in the generation of the 
mutagenic species. 
From Table 2 it can be seen that salicylamide, a substrate 
that is known to antagonize the sulfation reaction (Andersson 
et al., 1978) had no inhibitory effect on the mutagenicity 
data, whereas supplementation with a PAPS generating system 
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pre-incubation 
with 
hepatocytes 
23 
1510 
12 
160 
60 
pre-incubation 
without 
hepatocytes 
21 
161 
15 
37 
35 
1390 182 
TABLE 1 
Effect of different postmitochondrial liver fractions 
on the mutagenicity of benzidine after pre-incübation 
with or without intact rat liver cells 
Revertants TA 1538/plate 
 
subcellular liver fraction 
none 
9000 g supernatant + NADPH 
9000 g supernatant - NADPH 
microsomal fraction + NADPH 
105.000 g supernatant 
microsomal fraction + NADPH + 
105.000 g supernatant 
Benzidine (500 \¡M) was pre-inaubated with or without rat liver 
cells for 60 min as described in "Materials and Methods". After 
centrifugation the cell free supernatant was tested for muta-
genicity as follows: to 3 ml of molten topagar were added 0.5 
ml of this supernatant, 0.5 ml of different subcellular liver 
fractions from phénobarbital pretreated rats, corresponding to 
12.5 mg of liver tissue, in 0.15 M KCl (including a NADPH re-
generating system when indicated, consisting of 8 mM МдСІ2, 
4 mM NADP, 5 mM glucose-6-phosphate and 2.8 U/ml glucose-6-
phosphate dehydrogenase), and 0.1 ml of bacteria (ТА 1538), 
suspended in saline. 
Values, representing one typical experiment, are means of 
three different determinations. 
resulted in a substantial decrease in mutagenicity. The role 
of sulfotransferase is questionable therefore. However, 4-
aminoazobenzene and p-aminophenol, compounds that are known to 
inhibit the Ν,Ο-acyltransferase catalyzed adduct formation be­
tween N-hydroxy-2-acetylaminofluorene and t-RNA (King, 1974) , 
markedly reduced mutagenicity, whereas also paraoxon, an in-
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TABLE 2 
Effect of 4-aniinoazobenzene, p-aminophenol, paraoxon, 
salicylamide, anä PAP + pNPS on the mutagenic activa-
tion of benzidine by hepatic 9000 g supernatant after 
pre-incubation with intact rat liver cells 
Addition Relative mutagenicity 
(% of control) 
exp. 1 exp. 2 
37 
16 
69 
16 
44 
9 
none (= control) 100 100 
4-aminoazobenzene ( 50 μΜ) 
4-aminoazobenzene (250 μΜ) 
p-aminophenol (100 μΜ) 
p-aminophenol ( 1 mM) 
paraoxon (100 PM) 47 45 
salicylamide (1 mM) 121 107 
PAP (20 μΜ) + pNPS (10 mM) 29 21 
Benzidine (500 \¡M) was pre-incubated with rat liver 
cells for 60 min as described in "Materials and Methods". 
After oentriguation, 0.5 ml of the cell free supernatant 
was added to 3 ml of molten topagar, together with 0. 5 
ml 9000 g supernatant from liver of phénobarbital pre-
treated rats, corresponding to 12.5 mg of liver tissue, 
fortified with a MDPH regenerating system (= 5-g mix), 
0.1 ml of bacteria (TA 1538) suspended in saline and 
the compounds under test, added as concentrated solu-
tions in ethanol (salicylamide), DMSO (4-атіпоаго-
benzene, paraoxon) or saline (p-aminophenol, PAP + 
pNPS) to reach the final concentrations in the top-
agar as indicated. 
Values are means of three different determinations. 
hibitor of the de-acetylation reaction, reduced mutagenicity 
considerably. It should be noted that these compounds showed 
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no deleterious effect on bacterial viability at the concentra­
tions employed. These data are in favour of the concept that 
during incubation of benzidine with rat liver cells acetylated 
products are formed. This is also supported by the inhibitory 
effect of harmine, present during pre-incubation, on the ulti­
mate mutagenic activity (Table 3). 
TABLE 3 
Effect of harmine on the mutagenicity 
of benzidine when pre-incubated with 
rat liver cells 
Cone, harmine Relative mutagenicity 
(μΜ) (% of control) 
exp. 1 exp. 2 
0 (= control) 100 100 
100 69 84 
500 47 53 
Benzidine (500 \iM) uas pre-incubateci with 
rat liver oeVLs for 60 min in the presence 
of harmine. After centri fugation, 0.5 ml 
of the cell free supernatant was added to 
3 ml of molten topagar, together with 0.5 
ml S-9 mix and 0.1 ml of bacteria (TA 153B) 
suspended in saline. Values are means of 
three different determinations. 
In contrast to the observation that after pre-incubation of 
benzidine with isolated liver cells, cytosol fraction alone 
was not able to enhance mutagenicity (Table 1), it was found 
that in a direct plate assay rat liver cytosol markedly en­
hanced the liver cell mediated mutagenicity of benzidine (Fig. 
5). This is in accordance with the formation of a N-hydroxy-
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r e v e n a n t s TA1538/plate 
2 8 0 - , 
2 АО 
2 0 0 -
200 400 600 
benzidine cone ( >JM ) 
Fig. S Effect of rat liver aytosol (105.000 g supernatant) 
addition on the mutagenic activation of benzidine 
by rat liver cells. To 3 ml molten topagar were added: 
0.5 ml cell suspension (2.5 χ 10° viable cells/ml) or 
merely 0,5 ml suspension buffer, 0.5 ml hepatic ayto­
sol from phénobarbital pvetreated rats or 0.5 ml 0.15 
M KCl, 0.1 ml bacteria (TA 1538) suspended in saline, 
and 41 vl of different freshly prepared solutions of 
benzidine in DMSO. 
о : liver cells Δ : hepatic aytosol 
• : liver cells + hepatic aytosol 
Values (revertants/plate), representing one typical 
experiment, are means of deteiminations in triplicate. 
lated metabolite by rat liver cells. It might be that the 
relatively poor chemical stability of this particular type of 
metabolite is the cause of the observed difference between 
pre-incubation and direct plate assay. 
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DNA ехагегоп repair 
Besides the application of bacterial mutagenicity as a para­
meter for the extra-hepatocellular appearance of proximate and 
ultimate mutagenic metabolites of benzidine, DNA-repair was 
used as an endpoint for genotoxic effects of benzidine within 
the liver cell. Exposure of the cells to benzidine caused a 
concentration-dependent increase in H-TdR incorporation up to 
approximately 10 M benzidine (Fig. 6). Beyond this concentra­
tion an abrupt decline in incorporation was observed, possibly 
due to an injurious effect on the DMA-repair apparatus as such, 
-4 
since cellular viability was unaffected up to at least 5 χ 10 Η 
benzidine. 
3H.TdR incorporation 
(•/«•beve control ) 
50 
ίο
-
» ίο"
7
 io - 6 io"5 io"4 ισ3 
benzidine cone ( M) 
Fig. 6 The effect of harmine and saliaylamide on the enhanced 
incorporation of sH-TdR into hepatocellular DNA, due 
to benzidine exposure. Liver cells (1 χ 10 viable 
cells/ml) were incubated with different concentrations 
of benzidine, with or without addition of harmine (100 
\¡M) or saliaylamide (1 Ш). 
a: incubation with ( · ) or without ( о ) harmine 
b: inaubation with ( · ) or without ( о ) saliayl­
amide 
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When the N-acetylation and sulfation capacity of the liver cell 
were inhibited by harmine and salicylamide respectively, the 
enhanced incorporation of H-TdR was reduced to the level ob­
served in the absence of benzidine, suggesting that both N-
acetylation and sulfate conjugation are involved in the gene­
ration of reactive metabolites of benzidine, leading to DNA 
repair effects within the liver cell. It should be emphasized 
that both inhibitors had no effect on the enhanced incorpora­
tion of H-TdR evoked by dimethylmtrosamine and 4-nitroquino-
line-1-oxide (data not shown), thus excluding a deleterious 
action of harmine and salicylamide on DNA-repair mechanisms of 
the liver cell. Unfortunately we were unable to determine the 
effect of 4-aminoazobenzene, an inhibitor of the N,0-acylation 
reaction ги vitro, on the benzidine evoked hepatocellular DNA-
repair, since this compound itself is activated by the liver 
cell, thereby causing a substantial increase in H-TdR incor­
poration (Brouns et al., 1979b). 
DISCUSSION 
It is known from гп vitro studies that metabolic activa­
tion of benzidine can proceed via acetylation and hydroxylation 
of the amino function, after which a subsequent N,0-acyltransfer 
or sulfate coivjugation yield the ultimate reactive form (Morton 
et al., 1979, 1980). In the present study isolated rat liver 
cells were found capable to activate benzidine to metabolites 
causing genotoxic effects both inside and outside the liver 
cell. Besides the formation of metabolites that are directly 
genotoxic, data are presented about the extracellular appear­
ance of metabolic products that are not genotoxic as such, but 
can be more effectively activated by hepatic 9000 g supernatant 
than benzidine itself. From our data, together with those ob­
tained from in vitro studies by others, we composed a tentative 
scheme about the role of N-acetylation, N-hydroxylation, Ν,Ο­
Ι 34 
sulfation and Ν,Ο-acylation in the metabolic activation of 
benzidine by the intact rat liver cell (Fig. 7). Being aware 
of the complexity of the overall metabolism of benzidine, 
attention was focussed on the involvement of only one amino 
function. 
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Fig. 7 Tentative scheme for the metabolic activation of 
benzidine by isolated rat hepatocytes 
Our data are in favour of the liver cell mediated formation of 
metabolites that are directly mutagenic to Salmonella 
typhimuriion and are presumably formed through N-acetylation, 
N-hydroxylation, Ν,Ο-acyltransfer and/or deacetylation. It 
has been reported (Weeks et al . , 197Θ) that in the case of 
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N-hydroxy-2-acetylaminofluorene the Ν,Ο-acyltransferase cata­
lyzed mutagenic activation is unlikely to proceed via the 
formation of a N-acetoxy derivative, in contrast to the forma­
tion of reactive metabolites leading to t-RNA adducts. In the 
case of benzidine, however, the inhibitory effect of 4-amino-
azobenzene and p-aminophenol (Table 2), compounds that can 
serve as acceptors for the acyl moiety, suggests that an 
intramolecular transfer of the acylgroup to yield the N-acetoxy 
derivative may be involved in its mutagenic activation. Whether 
this type of metabolite can actually be regarded as a mutagen, 
either directly or after additional transformation, including 
bacterial activation pathways as suggested by Weeks et al. 
(1978) is still an open question. Furthermore, the inhibitory 
effect of paraoxon on the observed mutagenicity is in favour 
of the involvement of a deacetylation reaction in the mutagenic 
activation of benzidine. 
With respect to the release of benzidine metabolites from rat 
liver cells that require additional metabolic factors to become 
mutagenic, indications are presented that at least two types of 
metabolic products are involved. One is likely to be a N-ace-
tylated product, requiring both a microsomal and a cytosolic 
factor to become mutagenic, the other is activated by cytosol 
alone and is presumably a N-acetylated N-hydroxy derivative. 
Since it was found that the proposed N-acetylated metabolite 
was considerably more mutagenic than benzidine itself after 
metabolic activation by rat liver 9000 g supernatant, one may 
speculate about the impact of this phenomenon on the estimation 
of the genotoxic potential of benzidine. In this connection, 
the observed increase in mutagenic activity of benzidine after 
metabolic activation by intact liver cells, compared to 9000 g 
supernatant from these cells (Fig. 1), might be an indication 
of a better N-acetylation capacity of the intact cell. It can 
be concluded from Fig. 1 that in the case of benzidine, de­
struction of the biochemical organization of the intact liver 
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cell results in a decreased activating capacity. This observa-
tion is not a general phenomenon since with benzo(a)pyrene as a 
substrate, hepatocellular disintegration caused an increase in 
mutagenic response (Brouns et al., 1979a). These examples may 
illustrate the important value of isolated hepatocytes as 
metabolizing system in the evaluation of the genotoxic potential 
of premutagenic and precarcinogenic compounds. In terms of the 
extrahepatic genotoxicity of benzidine, the extrahepatocellular 
appearance of a N-acetylated-N-hydroxy metabolite may also be 
important, since the enzyme that is proposed to be involved in 
its mutagenic activation is localized not only in liver but 
also in various other tissues such as kidney, stomach, small 
intestine and colon. 
Our data on hepatocellular DNA repair are in favour of the role 
of both N-acetylation and sulfation in the formation of DMA 
adducts, that give rise to DMA repair (Fig. 6a, b ) . Since in-
hibition of the sulfation reaction had no effect on bacterial 
mutagenicity of benzidine, whereas stimulation by cofactor ad-
dition (PAPS) even reduced the mutagenic response, the role of 
sulfate esters in this respect is questionable, presumably 
because of their chemical reactivity and/or hydrophilic proper-
ties. From these discrepant findings it may be concluded that 
not necessarily the same metabolic products of benzidine are 
involved in the generation of mutagenic effects within Sal-
monella and the formation of DNA adducts within the liver cell. 
It remains an intriguing question which of these genotoxic para-
meters is actually related to the formation of carcinogenic 
metabolites of benzidine by the liver cell. 
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SUMMARY 
The formation of highly reactive metabolites, due to bio-
transformation of body foreign chemicals, which primarily takes 
place in the liver, has drawn much attention in toxicology in 
recent years, especially in the study of the mechanism of action 
exerted by genotoxic compounds. In the study on the relationship 
between metabolism and the occurrence of genotoxic effects, in-
cluding mutagenesis and carcinogenesis, it is generally accepted 
that these originate from interaction between metabolic products 
bearing an electrophilic centre and DNA. 
In order to understand the role of the liver in the conversion of 
body foreign compounds into these reactive products, many studies 
have been done in which subcellular hepatic fractions were applied 
as a metabolic system. The employment of such in vitro preparations 
often gives misleading information, both quantitatively and quali-
tatively, concerning the biotransformational processes that take 
place in the intact liver and that are determinant of the final 
toxic effect. For this reason attention has been focussed on the 
isolated intact liver cell in studying the relationship between 
metabolic parameters and genotoxicity for some model substrates. 
At first, a procedure for the high-yield preparation - under 
sterile conditions - of parenchymal cells from livers of adult 
male rats was set up, based on the collagenase perfusion technique 
(Chapter 2). Hepatocytes, thus isolated, were capable to activate 
potentially alkylating agents like styrene, paracetamol and 2-ace-
tylaminofluorene, whereas they were also able to inactivate toxic 
metabolites by hydratation and glutathione conjugation (Chapter 5). 
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In addition isolated hepatocytes appeared to be useful in the 
study of the relationship between subcellular localization of 
activating or inactivating enzyme systems and the occurrence of 
adverse effects. The use of isolated liver cells in future in-
vestigations on the role of the nucleus in the generation of 
reactive intermediary products may be worthwhile in this respect. 
The employment of intact hepatocytes as a metabolic system in-
stead of subcellular fractions in studies on bacterial mutagen-
icity was investigated. It was found that with some model sub-
strates intact hepatocytes provide data, different from those 
obtained with 9000 g supernatant from these cells (Chapter 6, 
Chapter 11). This is explainable, partly on the basis of differ-
ences in metabolic features, partly because of permeability 
barriers, thus preventing the toxic metabolites to leave the 
liver cell and reach the bacterial targets. 
The latter phenomenon was reason to investigate whether it is 
possible to detect genotoxic effects within the liver cell, thus 
being able to evaluate the formation of reactive metabolites in 
relation to their genotoxic action with the same cell system. 
It was established that in suspensions of isolated rat hepato-
cytes DMA repair occurs after exposure of the cells to chemicals 
that can be converted into electrophilic intermediates. An im-
proved method was introduced for a rapid quantification of DNA 
repair effects in hepatocellular suspensions using liquid 
scintillation analysis. Next, this approach was evaluated with 
some known carcinogens and their non-carcinogenic structural 
analogues. A good correlation was found to exist between the 
carcinogenic potential of these chemicals and their ability 
to induce hepatocellular DNA repair (Chapter 7). Hence, it can 
be concluded that measurement of DNA repair effects in suspensions 
of freshly isolated hepatocytes can be useful in studying possible 
carcinogenic properties of xenobiotics. Besides their applicabil-
ity in screening programs on carcinogenicity, isolated hepatocytes 
allow fundamental research on the various metabolic factors in-
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volved in the generation of electrophilic intermediates. Support 
was found for the hypothesis that the hepatocarcinogenic action 
of 7,12-dimethylbenz(a)anthracene is caused by metabolic trans-
formation of the methylsubstituent(s) (Chapter 6). Furthermore, 
indications were found that the carcinogenic aromatic amines 
2-aminofluorene, 2-acetylaminofluorene and benzidine can be 
metabolized via different routes, leading to reactive products, 
which can be distinguished with respect to their genotoxic ef-
fects (Chapter 9, Chapter 10, Chapter 11). The pathways leading 
to the formation of metabolites mutagenic in Salmonella are like-
ly to differ from those giving rise to metabolites that may evoke 
DNA repair effects within the liver cell. It is tempting to pro-
pose that the latter metabolites, which were found to interact 
with hepatocellular DNA, can initiate the carcinogenesis process. 
Despite the high sensitivity of bacterial mutagenesis test systems 
with respect to the prediction of genotoxic properties, the possi-
bility exists that for certain classes of compounds, as is examp-
lified in this thesis with some aromatic amines, mutagenicity and 
carcinogenicity do not necessarily share the same metabolic events. 
Therefore, assessment of carcinogenic properties by extrapolation 
of data on bacterial mutagenicity should be performed with some 
reserve. This implicates the almost imperative use of additional 
studies to understand the relationship between biotransformation 
and the initiation of cancer. The isolated rat hepatocyte proves 
to be a useful instrument in this respect. 
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SAMENVATTING 
Het feit dat bij de biotransformatie van lichaamsvreemde 
verbindingen, welke voornamelijk in de lever plaatsvindt, zeer 
reactieve Produkten kunnen ontstaan, heeft de laatste jaren sterk 
de aandacht getrokken in de toxicologie. Met name bij de bestu-
dering van de relatie tussen metabolisme en het ontstaan van z.g. 
genotoxische, o.a. mutagene en carcinogene, effecten wordt thans 
algemeen algenomen dat deze het gevolg zijn van interacties tus-
sen electrofiele metabole produkten en DNA. 
Teneinde inzicht te verkrijgen in de rol van de lever bij de 
metabole verandering van lichaamsvreemde verbindingen in deze 
reactieve metabolieten, worden meestal subcellulaire preparaten 
van lever als metaboliserend systeem gehanteerd. Het gebruik 
hiervan levert echter in veel gevallen misleidende informatie, 
zowel kwantitatief als kwalitatief, ten aanzien van de biotrans-
formatieprocessen, welke in de intacte lever plaatsvinden en 
welke mede bepalend zijn voor het uiteindelijk toxisch effect. 
Het is om deze reden dat in deze studie de intacte geïsoleerde 
levercel centraal heeft gestaan bij het onderzoek naar de relatie 
tussen metabole parameters en genotoxische activiteit voor een 
aantal modelsubstraten. 
In eerste instantie is een procedure, gebaseerd op de collagenase 
perfusie techniek, opgezet om routinematig onder steriele om-
standigheden parenchymatische cellen te isoleren uit levers van 
volwassen, mannelijke ratten (Hoofdstuk 2). De aldus verkregen 
hepatocyten bleken in staat te zijn potentieel alkylerende ver-
bindingen als styreen, paracetamol en 2-acetylaminofluoreen te 
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activeren, terwijl het vermogen om gevormde toxische metabolieten 
te ontgiften door middel van hydratering en koppeling aan gluta-
thion eveneens voorhemden was (Hoofdstuk 5). Tevens is gebleken 
dat geïsoleerde hepatocyten bruikbaar zijn bij het onderzoek naar 
de samenhang tussen subcellulaire localisatie van activerende en 
inactiverende enzymsystemen en het optreden van toxische effecten. 
Het gebruik van geïsoleerde hepatocyten bij toekomstig onderzoek 
naar de rol van de celkern bij de vorming van reactieve inter-
mediaire Produkten lijkt in dit verband zinvol. De toepassing van 
intacte levercellen als metaboliserend systeem in plaats van de 
gebruikelijke subcellulaire leverfracties bij bacterieel muta-
geniteitsonderzoek werd bestudeerd. Hierbij werden aan de hand 
van enkele modelsubstraten met intacte cellen andere resultaten 
verkregen dan met 9000 g supernatant uit deze cellen (Hoofdstuk 
6, Hoofdstuk 11). Deze verschillen in response zijn verklaarbaar 
deels op grond van verschillen in metabole mogelijkheden tussen 
beide systemen, deels vanwege perméabilité!tsbarrières, waardoor 
de gevormde toxische metabolieten niet in staat zijn de intacte 
levercel te verlaten en door te dringen tot de bacteriêle targets. 
Met name het laatstgenoemde verschijnsel is aanleiding geweest 
te zoeken naar een mogelijkheid genotoxische effecten te detec-
teren binnen de levercel, waardoor vorming van reactieve metabo-
lieten in relatie tot hun genotoxische werking aan een en het-
zelfde celsysteem geëvalueerd kan worden. In dit verband werd 
vastgesteld dat in suspensies van geïsoleerde rattelevercellen 
herstel plaatsvindt van DNA beschadigingen ten gevolge van 
blootstelling van deze cellen aan verbindingen welke omgezet 
kunnen worden in electrofiele intermediairen. Er werd een 
methode opgezet om in hepatocellulaire suspensies DNA reparatie 
effecten op een snelle manier te kunnen kwantificeren d.m.v. 
vloeistofscintillatie-telling. Deze methode werd vervolgens 
getoetst met een aantal bekende carcinogenen en hun niet car-
cinogene structuuranalogen. Hierbij werd een goede correlatie 
gevonden tussen de carcinogene potentie van de onderzochte 
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Stoffen en hun vermogen hepatocellulaire DNA reparatie te indu-
ceren (Hoofdstuk 7). Op grond hiervan kan worden geconcludeerd 
dat het meten van DNA reparatie effecten in suspensies van vers 
geïsoleerde levercellen goede perspectieven biedt bij onderzoek 
naar mogelijk carcinogene eigenschappen van xenobiotica. 
Naast de genoemde mogelijkheden voor toepassing in het praktijk-
gerichte carcinogeniteitsonderzoek, bieden geïsoleerde hepato-
cyten eveneens de mogelijkheid tot fundamenteel onderzoek naar 
de diverse metaboIe factoren, die bepalend zijn voor de vorming 
van reactieve intermediaire Produkten. Er werd een ondersteuning 
gevonden voor de hypothese dat de hepatocarcinogene werking van 
7,12-dimethylbenz(a)anthraceen het gevolg is van metabole ver-
andering van de methylsubstituent(en) (Hoofdstuk β). Voorts 
werden aanwijzingen verkregen dat de carcinogene aromatische 
ami ηen 2-aminofluoreen, 2-acetylaminofluoreen en benzidine door 
de levercel langs verschillende metabole wegen kunnen worden om­
gezet in reactieve Produkten, welke onderscheiden kunnen worden 
op grond van hun genotoxische effecten (Hoofdstuk 9, Hoofdstuk 
10, Hoofdstuk 11). De metabole wegen welke leiden tot metabo-
lieten, die mutageen zijn in Salmonella, blijken te verschillen 
van die, welke bepalend zijn voor de vorming van produkten die 
in de levercel DNA reparatie effecten kunnen induceren. Het is 
aantrekkelijk te veronderstellen dat deze laatste, welke een 
interactie met het hepatocellulaire DNA aan kunnen gaan, het 
carcinogenese proces kunnen initiëren. 
Ondanks de grote voorspellende waarde van bacteriele mutageni-
teitstesten bij het vaststellen van genotoxische eigenschappen, 
bestaat de mogelijkheid dat voor bepaalde groepen verbindingen, 
zoals in dit proefschrift aangetoond voor enige aromatische 
aminen, mutagene en carcinogene activiteit niet noodzakelijker-
wijze het gevolg zijn van dezelfde metabole transformaties. 
Derhalve dient het toekennen van carcinogene eigenschappen door 
extrapolatie vanuit bacterieel mutageniteitsonderzoek met enige 
reserve te geschieden. Om inzicht te verkrijgen in de rol van 
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biotransformatieprocessen bij het ontstaan van kanker is addi-
tioneel onderzoek dan ook dringend gewenst. In dit verband kan 
de geïsoleerde rattelevercel een bruikbaar hulpmiddel zijn. 
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STELLINGEN 
I 
De aanname van Tong et al., dat de intrinsieke capaciteit 
van gekweekte epitheelcellen uit rattelever om xenobiotica 
te metaboliseren - als toegepast in de zgn. adult rat li-
ver epithelial cell/hypoxanthine-guanine phosphonbosyl-
transferase(ARL/HGPRT) mutageniteitstest - vergeli]kbaar 
is met die van primaire levercelculturen, is onjuist. 
Tong et al.. Mutation Research 74_ 1-9 (1980) 
II 
Het gebruik van microsomale preparaten van verschillende 
humane weefsels als activenngsbron in de Ames-test, met 
als doel orgaangevoeligheid voor chemische carcinogenen 
te bepalen, is niet zinvol. 
III 
De rol van anaerobe processen, met name in de darm, bij 
de vorming van electrofiele intermediaire metabolieten 
wordt niet voldoende onderkend. Onderzoek naar de toepas-
baarheid van anaerobe technieken in bacteriële mutageni-
teitsproeven dient dan ook te worden gestimuleerd. 
IV 
Gelet op het stimulerende effect van poly-onverzadigde 
vetzuren op de incidentie van mamma adenocarcinomen bij 
de rat, dienen uitspraken, dat deze vetzuren de gezond-
heid zouden bevorderen, met reserve te worden gehanteerd. 
Hopkins et al., J.mtl.Cancer Inst. £6 517-522 (1981) 
V 
Op grond van een evidente anticarcinogene werking van 
selenium, dient de mogelijkheid tot een toxicologisch 
aanvaardbare selenium suppletie van voedingsmiddelen, 
bijvoorbeeld margarine, onderzocht te worden. 
Griffin et al.. Adv.Cancer Res. 29 419-442 (1979) 
VI 
Aangezien een aantal gevallen van " sudden infant death 
syndrome" te wijten is aan toxico-infectie met Clostridium 
botulinum, dient men alert te zijn op de aanwezigheid van 
dit organisme in bijvoeding aan pasgeborenen en op contami-
natie-mogelijkheden bij de bereiding van babyvoeding. 
Arnon et al. y J. Am. Med. Ass. 2Z7_ 1946-1951 (1977) 
vu 
Bij dierexperimenteel onderzoek naar toxiciteit van xenobio-
tica wordt te weinig aandacht besteed aan mogelijke effecten 
van de te onderzoeken stoffen op toxificerende en detoxifi-
cerende enzymsystemen. 
VIII 
Gezien de aanwezigheid van zowel mono-oxygenase als epoxide 
hydratase in de celkern, is het niet ondenkbaar dat dit or-
ganel een essentiële rol vervult bij de bioactivenng van 
een aantal premutagene en precarcinogene verbindingen. 
IX 
Een verhoogde excretie van thioethers in urine is niet indi-
catief voor belasting met carcinogenen. 
X 
Voor die carcinogenen, waarbij naast genotoxische activiteit 
ook cytotoxiciteit een rol speelt bij tumorvorming, is het 
one-hit extrapolatiemodel, teneinde een verantwoorde risico-
schatting voor de mens te maken, te conservatief. 
XI 
Bij studies naar de effecten van dieetmodificaties op de 
endocriene status van proefdieren, dient de invloed van 
stress op hormonale regulatie-mechanismen onderkend te 
worden. 
XII 
Gezien de weinig daadkrachtige aanpak door de overheid om 
de blootstelling aan notoire carcinogenen in tabaksrook te 
reduceren, moeten miljoenen verslindende operaties teneinde 
chemisch vervuilde bodem te zuiveren van relatief minder 
gezondheidsbedreigende contaminanten, hoe terecht dan ook, 
als inconsequent worden beschouwd. 
XIII 
Het valt te verwachten dat de machtsgreep van de micro-
electronica resulteert in een stijgende behoefte aan cardio-
logen en neurologen. 
Rob Brouns 
Nijmegen, 23 oktober 1981 



